Ruth Wishart on Kenneth Roy’s diary of living and dying – HeraldScotland

ICS Books, 14.99

Intimations of mortality arrive in different ways, and at different speeds.

Some are a normal function of the ageing process; physical impairment being an irritating sign that whatever the mind is saying, the body is making its own judgements as to likely longevity.

But perhaps the most devastating indication that life is finite comes to those whose illness and swiftly following demise arrives with little prior warning, giving the unexpected patient little time for mental or emotional preparation.

That was the shocking fate which befell the Scottish writer, broadcaster and publisher Kenneth Roy. His diagnosis of a terminal cancer was delivered in October of last year. He was dead little more than a month later. And his last very few weeks were spent in a hospital room, attended by a cast list of NHS personnel with whom he seems to have established a relationship of mutual respect and affection far exceeding the normal staff patient variety.

It was they, and in particular his consultant, who by turns encouraged and chivvied him in his last defiant rage against the dying of the light. It began as a diary; a written account of his daily treatments and failing health, interspersed with memories of his troubled childhood, and myriad subsequent ventures and friendships.

For Roy words were ever the stuff of life, and he wielded them one final time to challenge onrushing death by crafting an astonishing 49,000 words which became posthumously a book, latterly composed with one fingered typing. In Case of Any News: A Diary of Living and Dying was a title he seized upon when one of his two sons indicated it was why he left his phone always on and handy when he heard of his fathers plight.

The book gives no little insight into the life and character of this complex man; a clever child who became a serial truant at his secondary school. He left without much in the way of qualifications when, doubtless to fulfil his fathers injunction to be something, he had always envisaged university as the primary punctuation point to his education.

He writes unsparingly of teachers whom he accuses of sadistic use of the belt due to psychological flaws. Yet he is sufficiently curious and self aware to ponder why his peers were able to survive and prosper in the same environment.

His life became one full of both achievement and contradictions. He wrote widely for a number of publications, always with a trademark iconoclasm. Nevertheless, although a kenspeckle TV face for a period, he seemed happier operating from rural Ayrshire than a high octane newsroom. All of a piece with his unwavering support for a defiantly unfashionable football team, rather than those in more glamorous leagues.

Amid many ventures, some more successful than others, were two which offer a considerable legacy: his Young Programme, which encouraged interaction and debate among younger people UK-wide and The Scottish Review, which he edited until his death and in which, typically, he broke the news about his impending death. A much followed-up scoop, but not one he would have wished to acquire.

But this book is more than just an autobiographical memoir. Rather it is an account all too vivid at times of the many indignities visited upon a person when he or she can no longer exercise proper control of their own bodily functions. (Not the least of the dark humour he intrudes regularly is pondering the prospect of having to die facing two signs marked Toilet.)

There is throughout a strong thread of philosophical inquiry; interrogating his own agnosticism, musing on the random nature of death and disease, examining unfulfilled ambitions. And it is in these passages that Roy's sometimes perplexed reflections will strike the most resonant chords with readers.

For we are all familiar with death in its many guises, and all have personal experience of dealing with it in relation to those close to us. Reading this account of his final weeks reminded me forcibly of my own husbands diagnosis and death, again within a month. Yet he was spared the traumatic events of final weeks spent in an unfamiliar bed, tended to by strangers, or awareness of the end game. A death following a failed surgical process is shattering but not to the patient, mercifully granted no sense of impending doom.

Most people, when they consider their time on this earth, have similar views as to how they would wish to leave it. Very few harbour a wish to die in hospital yet most of us do. What most of us fear is not death per se, but decrepitude and dependency.

A couple of years ago, at a book festival, I was interviewing an eminent Irish doctor. His very firm view was that the process of dying had been wrenched from familial control and subjected to unwarranted medicalisation. He thought striving officiously to keep alive was far from the optimum response when the life in question had been well-run and reached a natural conclusion.

Yet handing back control to the nearest and dearest of the about to depart is not without its own attendant risks. Many relatives actively connive in demanding procedures when they can inevitably only prolong agony whether physical or mental. Many choose to ignore the very specific wish of their loved one that their organs be deployed to alleviate other human distress.

In recent years we have seen heart-wrenching examples of parents who demanded their infant be kept alive, or dispatched to foreign parts for experimental treatment, when the medical team most intimately involved have counselled that further intervention would be both pointless and not in the best interests of the child.

The whose life is it anyway? conundrum is most acutely relevant in the other high-profile cases of recent times when people suffering from desperately debilitating conditions conclude that their life is not worth living, but whose cries of impotent distress are thwarted by politicians or those with a theological axe to grind. I can see no scenario where we should feel proud of forcing people to travel abroad in order to extinguish an impoverished facsimile of life, a mortal coil being shuffled off only to avoid a living death.

Life expectancy has improved for most people, and broadly that is to be welcomed. Yet the bald statistics do not factor in quality of life. There are 80-somethings rejoicing in their ability to still run half marathons. There are others locked in the torment of advancing dementia.

Kenneth Roy bemoaned the fact that he left our world aged 73. Ive never thought of 73 as an age to die, he wrote. Its a score in an Open Championship, respectable enough but on the fringes of contention at best. But arguably its not the time you are allotted so much as what you do with it. Roy may have felt cheated of another decade or so. But he packed an impressive amount into his three score years and three.

Visit link:

Ruth Wishart on Kenneth Roy's diary of living and dying - HeraldScotland

This Marketing Agency Wants To Put The Pleasure Back Into The Sex Tech Business – Forbes

Its easy to get excited about the financial opportunities of the sex tech industry. But marketing agency Healthy Pleasure Collective wants to put the pleasure back into the sex tech business. By acknowledging individual sexuality and prioritising customers sexual fulfillment, the agency believes brands can not only advance faster, but have a positive social impact too.

The sexual wellness market accounted for $39 billion in 2017 and has been estimated to be growing at a 30% annual rate. With the industry predicted to be worth $122 billion by 2026 investing in sex tech looks like a good move.

At Healthy Pleasure Collective, fundraising and development are about more than making money. Founded by business and brand architect Dominnique Karetsos and Dr. Maria Fernana Peraza Godoy, a urologist, andrologist and sexual medicine expert, HCP is a full service agency dedicated to sex tech. The team offers consulting, fundraising, branding, product development, digital marketing, communications, press and business development for entrepreneurs in the field of sexual health and wellness technology. HCP seeks to innovate, advance and build sexual health and technology brands while holding onto the key factor motivating all our interactions with them: pleasure.

Dominnique Karetsos is the co-founder of Healthy Pleasure Collective, a full-service agency ... [+] dedicated to sex tech startups

The pursuit of pleasure is inherently human, say the founders. When we leave it out, we not only ignore a crucial part of the user experience, we neglect to recognise a vital part of our humanity. By tapping back into this, they say, products and solutions can thrive in the market while also having a positive impact on sexual health and wellness.

I caught up with Dominnique Karetsos to find out how brands can go about mixing pleasure with business.

Franki Cookney: What prompted you to set up an agency dedicated to sextech startups?

Dominnique Karetsos: I have been an entrepreneur and consumer brand architect for almost 20 years, but eight years ago I was a co-host on BBC Radio London, and it was that experience, combined with becoming a mum of a daughter, that led me to personally and socially understand the intrinsic value of sexuality in living a healthy, fulfilling life.

Dr. Mafe Godoy (we call her Mafe) supported me while I architected sex toy brands, repositioning them as healthy, even after people slammed phones on me and others threw me out of meeting rooms. We joined forces and curated a collective of experts in a space dedicated to this industry.

Dr. Maria Fernana Peraza Godoy, a urologist, andrologist and sexual medicine expert, who co-founded ... [+] the Healthy Pleasure Collective

Cookney: What specific needs does the sex tech industry have when it comes to marketing and brand development?

Karetsos: The one that screams help is language. We need digital marketing channels and platforms, namely Google, Facebook, Apple, and Instagram, to educate, engage with and enhance experiences with our marketing messages. But they chip away at our strategies with ignorant and inflexible algorithms, shadow-banning us and shutting us off. Brands entering in this space who invest in an app run a high risk of being shut down. So the strategy for digital marketing has to be a well thought-out process. It has to be tested, tested and tested again, and the language has to be adapted but not diluted. Brand tones must be authentic but still steer clear of being stereotyped by an algorithm.

Cookney: What specific challenges does the sex tech industry face?

Karetsos: Our industry may be robust in value but we are finite in people. Attracting skills is a tough feat. There is no sex tech chapter at university or college or at school level economics, and there is certainly no 101: How to Market Sex Toys in advertising class. We are seeing a slow but positive upturn but not fast enough to meet the growth at which sex tech start-ups are scaling.

Cookney: What has changed in the way sexual wellness products get marketed?

Karetsos: Before sex tech, we started with adultthe sex toys and movies we bought down a dark alley in a brown paper bag. And anything sexual in daylight was and still is largely polarised as either porn or family planning.

It is fair to say we have migrated from adult to sexual health awareness. We have dating apps for all sexual identities, fertility apps, long-distance vibrating toys, AI dolls being used in mental health treatment. But it is still very apparent that our industry is like an uncomfortable teenager struggling with what to call ourselves, and not knowing if its more socially digestible to say sex tech or sexual wellness.

Cookney: Why is it so important to you to integrate sex tech and sexual wellness with health?

Karetsos: Sex is a health issue. Through sex tech we make room for the importance of sexuality and its inherent value in our lives. The World Health Organization defines sexual health as a state of physical, mental and social well-being in relation to sexuality. It says that it requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence. But to date we have not incorporated sexuality as part of our social understanding of global health.

Cookney: How does this message impact a companys marketing strategy?

Karetsos: In the traditional sense of marketing, knowing who your target audience is to curate your message is vital to your communication strategy. But in sex tech, every human who is of age to associate with a sexual identity is potentially your audience. But they will not all become your customer. Emily Nagoski said it best when she said: There are as many sexualites as there are humans. No one sexuality is the same, so a marketing strategy that throws paint at the wall and hope it sticks will not bring sustainable longevity in brand share.

We must care enough to educate and nurture sexualities, developing the tools that enable people to explore in safe spaces, judgement free. Be it a fertility tracking software or an educational video on how to masturbate, brands should consider who and how to market, and not just provide labels that society insists upon.

Cookney: What have you learnt about the sex tech sector since founding HCP?

Karetsos: The sector is still largely polarised. On one side you type vulva or illustrate a nipple and social channels can close an account in an instant. While in other mediums we trivialise sexwe use it sell everything. But within this polarised market lie pockets of radical innovation. For example, we have an all-out warfare on porn (rightly or wrongly). But most of us watch it at some point so instead let us change the scripts to illustrate consensual, ethical, real life experiences. Cue the rise of female audio porn start-ups.

Sex techs potential to change the biomedical industry, and enhance research in a field as overlooked as female sexual health, is another learning we have had. Its not just about developing devices, but also the development of knowledge from big data that many apps are already collecting. This data will lead to the development of new treatments in female sexual functioning, including diagnostic and therapeutic devices.

Cookney: What challenges do you think the sector faces in the future and how can these be met successfully?

Karetsos: A megawatt spotlight needs to be shone on regulation. We are not a regulated industry so brands have the freedom to promise anything and not be held accountable. Only now ISO regulations are coming into action ensuring that medical grade silicone, used for menstrual cups and toys, are of healthy compliance.

However, despite the challenges, we honestly only see positive change and impact. Maybe it is not as fast or forward moving as we would like but six months ago, sexual wellness was not listed as an independent category in Boots pharmacy or even included in trend emersion beauty reports.

The sex tech industry is responsible for amplifying our beliefs and habits that consensual pleasure is healthy, good and invaluable to our lives as individuals and couples.

The conversation has been edited and condensed for clarity.

Originally posted here:

This Marketing Agency Wants To Put The Pleasure Back Into The Sex Tech Business - Forbes

Lewis Hamilton is not only a peerless champion, he is the face of F1 – The Guardian

With a sixth world championship this season, Lewis Hamiltons place in motor racings pantheon is assured. Debate will rage over who may be the greatest of all but Hamilton, the black kid from a Stevenage council estate, surely occupies a position no other has managed. He has transcended the role of driver to perhaps a unique place in the sports history. To a broad global audience, Formula One is Lewis Hamilton.

With five titles from the past six seasons, this is the Hamilton era. He is the pre-eminent driver of his generation and the focal point of F1. A personality that is impossible to ignore and who stands astride the sport like no other.

Hamilton is that rarest of breeds, a sportsman who, it could be argued, is genuinely peerless. He has faced down and beaten the outstanding talents of Fernando Alonso and Sebastian Vettel. He has unashamedly relished the fight, and neither the longevity of his 13-year career, nor the success, nor the new threat from the young guns of Max Verstappen and Charles Leclerc, has diminished his enthusiasm.

The core of what I do is that I love racing, he said. I love the challenge. I love arriving knowing I have got these incredibly talented youngsters who are trying to beat me and outperform me, outsmart me, and I love that battle I get into every single year.

His performance in securing the title again for Mercedes this season, which draws to a close in Abu Dhabi on Sunday, was as good as any of his previous five. Indeed as of any of his 13 seasons since he entered F1 in 2007. Hamilton has been in a class alone, a driver at the top of his game with an iron-willed resilience, debilitating to his rivals.

David Richards, the chairman of Motorsport UK, first watched an eight-year-old Hamilton race in karts. Richards recognises how far he has come and his place in the bigger picture of F1.

Hamilton is in a class alone, a driver at the top of his game with an iron-willed resilience, debilitating to his rivals

What strikes me now about him now is his maturity, he said. How he recognises he is a role model and the influence he has and the responsibilities that come with it. He is far broader than purely a driver in F1. He has opinions about the environment, young people, fashion and music. That is part of the greater appeal of Lewis today.

Intriguingly during Hamiltons debut season for McLaren in 2007, Jackie Stewart saw exactly this potential. I think Lewis is going to rewrite the book, Stewart said. I believe Lewis will create the benchmark for a whole generation of drivers. Niki Lauda and James Hunt changed the culture of racing drivers, but they werent role models. They said nothing, didnt give a damn. Lewis Hamilton can become a role model.

Hamilton is that benchmark now. In recent years, record after record has fallen to him and only two remain. He is one championship behind Michael Schumachers seven and eight GP wins behind the Germans 91. Both are well within the 34-year-olds reach.

Close, then, to becoming the most successful of all time, last week Hamilton appeared on the Graham Norton show, sharing a sofa with Kylie Minogue, Ricky Gervais and Elizabeth Banks. It was an indication of the position he occupies. There is no other current driver that one might even imagine would be asked to take part.

That such fame has accompanied his achievements is not surprising. Yet his rise to this position has not been simple cause and effect. At its heart has been relentless dominance on track, born of a commitment for which he is not given enough credit, but also there is the way he has gone about his racing and the honesty of a man who wears his heart on his sleeve.

His recent post on Instagram expressing a sense of helplessness in the face of the climate emergency received huge traction and not a little criticism given his chosen sport, which he had to take on board.

There is a lot of push-back on a lot of things I do, and a lot of questioning of everything I do and say, he said. You live your life under a magnifying glass. Were only human, so at some stage youre going to buckle a little bit.

In a sport where technology is king this is the very relatable humanity of the man behind the wheel. Nonetheless it is on the track where he has made his most striking statements.

This season Hamilton won eight of the opening 12 races. Ferraris challenge failed to materialise and his Mercedes teammate, Valtteri Bottas, was beaten back after a spirited opening. Bottas remains his closest rival with four wins but numbers are cold, blunt objects with which to frame Hamiltons artistry.

From a superlative season, outstanding moments come to the fore. Making the bold gamble of taking hard tyres for a one-stop at Silverstone work; coming back to beat Verstappen in Hungary after driver and team errors in Germany. His touch in nursing spent rubber to the flag in Monaco, and the complete control of taking a race he should never have won with a damaged car in Mexico.

Mercedes have largely enjoyed the better car this season but it is not an advantage Hamilton has always enjoyed. Certainly for three championships, that of his first title in 2008 for McLaren and in 2017 and 2018, he was not in the quickest car. Perhaps of more import has been how he has gone about the task. Even between 2008 and his second next title in 2014 he remained compelling. Always striving for more than his machinery could offer and often delivering. He won at least one race in every one of those seasons and is the only F1 driver to have won every year in which he has competed.

In that time there has been no sense Hamilton has been anything but an honourable competitor. The former driver Johnny Herbert astutely identified this as another reason Hamilton has such broad appeal. He is the toughest man and the fairest man on track, Herbert said. He wants to do it in a way where he doesnt get an advantage, he wants a good battle.

For F1 and its owner, Liberty Media, these attributes are a fearsome combination. Hamilton takes the sport to an audience beyond any other driver. His presence on Instagram is unmatched by anyone in F1, with 13.7m followers. In the US, where Liberty is determined to build the sport, he is the star who reaches a mainstream audience.

From this perspective then, Hamilton is intrinsic to F1 as no other. The talent of youngsters such as Verstappen and Leclerc is hugely exciting and promises that on the track the sport is in rude health. But they will take time to even approach matching Hamiltons global reach.

He has one further year on his contract with Mercedes and F1 needs him to stick around. Fortunately as things stand Hamilton appears to have no intention of stepping down but rather, continuing at the top with the same belief that proved remarkably prescient in 2007.

The race is the most exciting part, he said in his debut season. The first corner, the first pit stop. I am just going to get stronger and stronger. Im not yet at my best.

More here:

Lewis Hamilton is not only a peerless champion, he is the face of F1 - The Guardian

Recent deaths at Dallas Zoo have seemed notable but aren’t out of the ordinary – The Dallas Morning News

Hope, a 23-year-old gorilla, was well short of the 39 years female gorillas in captivity typically live to when she died earlier this month at the Dallas Zoo.

The zoo has yet to announce the cause of death for the mother of Saambili the zoos first baby gorilla in 20 years but says her death and those of a few other notable animals in recent months are isolated incidents and nothing out of the ordinary.

Its accrediting institution echoes the parks statement, saying there is no cause for concern.

Three animals have died this year in unrelated incidents that werent associated with old age a giraffe and an African painted dog, in addition to Hope. The zoo has been upfront about the deaths, posting about each on social media along with a reflection on the animals personality and time at the zoo.

Visitors have noted the recent losses in replies on Facebook and others commended the zoo on its candidness in sharing the information.

In a written statement, the zoo said its openness in the stories it tells has helped the public connect with all aspects of the animals' lives.

"That includes births, key milestones, birthdays, health challenges, and even deaths," the zoo said. "Given that we work with a living collection, life and death is a part of our everyday."

Hope died suddenly Nov. 3 after she and other gorillas in the zoos family troop had experienced mild gastrointestinal symptoms. Tests for parasites and other pathogens were negative, but a necropsy found that her colon was severely inflamed, the zoo said.

The zoo has said the final tests to determine her cause of death are still pending. Other gorillas, including Megan and her son, Mbani Saambilis half-brother are continuing to recover but seem to be past the worst of the illness, the zoo said.

Saambili, who was born in June 2018, was understandably shaken by the loss of her mother, the zoo said. In the days that followed, her father, Subira, stayed near her side and other members of the family troop took turns holding her.

She has also been strengthening her bond with her aunt Shanta, who often carries Saambili around on her back a bright spot in the midst of sadness," according to the zoo.

Gorilla family bonds are strong, and the other family members have stepped in to support and comfort her, the zoo said in a prepared statement.

On the Fourth of July, just weeks after an introduction that zoologists said had gone better than expected, African painted dog Ola was killed by her two packmates.

The zoo described the attack as a "short bout of aggressive behavior" from the two brothers who were behaving naturally and did nothing wrong.

There had been no aggression between the animals who met in a high-stakes introduction a month earlier, the zoo said, adding that it believed the staff could not have prevented the incident.

Her death was another blow for the staff and for zoo guests who had recently learned that the giraffe Witten, named after the Dallas Cowboy, had died June 17 during an exam.

The zoo initially thought the giraffe had stopped breathing at the beginning of a procedure in reaction to a sedative. He was being examined for health issues ahead of a transfer to a Canadian zoo.

A necropsy showed that he thrashed around before the sedative took effect and broke a bone in his neck, which killed him almost instantly, the zoo said.

The zoos internal review of the incident revealed no issues with policies that were in place or veterinary procedures. A recommendation was made to make minor modifications to the device that is used to manage giraffes during veterinary procedures.

The change would not have altered the outcome but could make future procedures more efficient, the zoo said.

Rob Vernon, a spokesman for the Association of Zoos and Aquariums, the zoos accrediting agency, said this summer that sometimes deaths occur around the same time but that they are not connected or reflected on the care provided at the zoo.

"I can tell you that there's nothing out of the ordinary in any of the deaths that have occurred at the Dallas Zoo," Vernon said. "Death is a reality for any of us caring for living things and it's something that we deal with on a normal basis."

The U.S. Department of Agriculture, which licenses zoos and other similar exhibitors, identified no "non-compliant items" during its annual inspections of the Dallas Zoo in 2017, 2018 and 2019. The most recent inspection took place June 24, days after the giraffe's death.

No non-compliances were found related to the death of the African painted dog, Ola, either, according to the USDA.

The AZA does not track deaths in U.S. zoos, but Dallas keeps a record of its own.

For the last 10 years worth of data, the zoo said it averages 3.1 deaths a month. Through October, the number of deaths in 2019 has been about 5 percent below that average.

While weve experienced the deaths of several well-known animals among high-profile species, there is nothing out of the ordinary about the number of animal deaths that have occurred at the Dallas Zoo in the previous year, the zoo said in a statement.

AZA zoos are required to contact the association in the event of an accident with an animal or a keeper, which Dallas has done especially in the case of a notable animal death, Vernon said.

If the AZA learns of unusual circumstances at a zoo, he said, it can send in a team to investigate, but whether a zoo loses its accreditation is a case-by-case basis.

In March 2018, the Baton Rouge Zoo lost its 40-year accreditation after inspectors noted three animal escapes in 16 months, outdated facilities and a 2016 incident in which dogs broke into the zoo and killed three monkeys, The Advocate reported.

The incident followed the unexpected deaths of two giraffes and a tiger for which the zoo was cleared of any wrongdoing, according to The Advocate.

The Dallas Zoo's accreditation runs through March 2022. The zoo, which has been an AZA institution since 1985, has been a "stellar member," Vernon said.

Animal-rights groups often object to the keeping of animals in zoos, citing claims of behavioral issues, threats of disease, added stressors and poor facilities.

Both the AZA and Dallas Zoo argue that animals in zoos get a level of care and safety from predators, the weather and other factors that they would not get in the wild. The zoo has also stressed its efforts to provide animals with enrichment.

A 2016 analysis published in the journal Scientific Reports found, based on a variety of factors, that mammals in zoos generally live longer than those in the wild.

There are some exceptions. Species that have a slower pace of life, which is linked to low mortality, and those that have high longevity in the wild may not see their life expectancy lengthened in zoos.

The study also added that carnivores may need husbandry techniques to reduce the behavioral abnormalities that they are more susceptible to in zoos.

But animals with a short life span, high reproductive rate and high mortality in the wild may see the benefits.

The zoo has experienced several notable deaths in recent years: Adhama, a 7-year-old hippo who died suddenly of heart-related complications from a viral infection in October 2018; Kipenzi, the 3-month-old giraffe who died instantly when she broke three vertebrae in her neck in July 2015; Kamau, a popular 6-month-old cheetah cub who died of a respiratory illness in January 2014; and 5-year-old lioness Johari, who was killed by one of the zoos male lions in November 2013.

Those deaths grab more attention than others, perhaps in part because of the non-natural causes or because the animals have been visible for their species at the zoo.

The zoo has also shared a number of age-related deaths on its social-media accounts.

The zoo lost Doyle, a 49-year-old chimp the third-oldest male in the AZA to age-related health issues in June. Male chimps typically live to be 31.4 years old in human care, according to AZAs survival statistics table.

In April, a 29-year-old okapi named Kwanini died, having far outlived the 16.4-year median life expectancy for the species, according to AZA statistics.

Other deaths included Honeydew, the oldest tapir in the AZA, who died of age-related issues in January shortly before turning 38.

Staff writer Tom Steele contributed to this report.

See the original post here:

Recent deaths at Dallas Zoo have seemed notable but aren't out of the ordinary - The Dallas Morning News

A conserved ATP- and Scc2/4-dependent activity for cohesin in tethering DNA molecules – Science Advances

INTRODUCTION

The establishment of sister chromatid cohesion is essential for accurate chromosome segregation during the mitotic cell cycle. Cohesin is a complex of the SMC (structural maintenance of chromosomes) family originally identified for its role in tethering sister chromatids from S phase until anaphase (1, 2). In addition to its function in sister chromatid cohesion, cohesin modulates the organization of interphase nuclei and mitotic chromosomes (1, 3, 4). Studies in vertebrates have shown that cohesin complexes maintain contacts between different loci in cis and in this way contribute to the folding of individual chromatids into distinct loops that provide an integral level of genome architecture (1, 3, 4). The current model for how SMC complexes, including cohesin, might form DNA loops involves the capture and bending of DNA segments followed by progressive enlargement of these to form loops (5, 6); this activity has been termed loop extrusion. Evidence for this model has been obtained from in vitro analysis of purified yeast condensin (7). Cohesins most prominent function is the tethering of sister chromatids, which is expected to involve an ability to bridge two DNA molecules in trans. Unlike condensin, cohesin has not yet been demonstrated to extrude loops in vitro. A potential activity in loop extrusion has been suggested for cohesin because of its involvement in the maintenance of cis looping and as a potential linear tracking mechanism that could explain the preferential use of convergent CTCF DNA motifs at TAD borders during genome folding (8, 9). However, it is currently not clear how loop extrusion could explain the well-established role of cohesin in sister chromatid cohesion.

Mechanistically, we only have a vague idea of how cohesin might generate intermolecular tethers while mediating sister chromatid cohesion. Two main models have been proposed to explain cohesin function in sister chromatid cohesion: the ring or embrace model (10, 11), in which a single cohesin ring entraps both sister DNA molecules (10), and the handcuff model, where sister chromatid cohesion is mediated by the entrapment of sister DNAs in different cohesin complexes and a subsequent cohesin-cohesin interaction (1, 12, 13). The capture of the pair of double-stranded DNA (dsDNA) molecules during the establishment of sister chromatid cohesion by a single cohesin molecule in the embrace model has been proposed to occur by either (i) passage of the replisomes through the ring lumen of a DNA-bound cohesin or (ii) when a DNA-bound cohesin captures a single-stranded DNA (ssDNA) at the fork, which is then converted into dsDNA by DNA synthesis (14). Although cohesin complexes have been purified from fission yeast (15), frogs (16), and human cells (17), single-molecule analyses of DNA bridging activities have not been reported. Purified cohesin complexes have been shown to exhibit DNA binding activity in a salt-resistant manner (18) and to rapidly diffuse on DNA; however, these were shown to be independent of adenosine triphosphate (ATP) (1517), suggesting that they are not at the core of its ATP-dependent activity.

Single-molecule studies of purified yeast condensin have shown that this SMC complex compacts DNA molecules on magnetic tweezers (19), translocates along linear DNA molecules in an ATP-dependent manner (20), and forms DNA looplike structures on surface-tethered, flow-stretched DNA (7). Furthermore, while purified condensin exhibits robust ATPase activity in the presence of DNA (19), purified yeast cohesin is a poor ATPase on its own (21, 22). Recent work has shown that the Scc2-Scc4 loader complex greatly stimulates cohesins ATPase activity (21, 22). On the basis of these findings, we sought to investigate activities of budding yeast cohesin in the presence of the Scc2-Scc4 loader complex using the following two complementary single-molecule approaches: DNA curtains and optical tweezers.

To investigate activities of yeast cohesin using single-molecule assays, we first purified budding yeast cohesin tetramers, containing Smc1, Smc3, Scc1/Mcd1 (thereafter referred to as Scc1), and Scc3, from exponentially growing yeast cultures (Fig. 1A). Cohesin subunits were overexpressed in high-copy plasmids using galactose (GAL)inducible promoters. Purified material was obtained via affinity chromatography, using a triple-StrepII tag fused to the Smc1 subunit, followed by passage through a HiTrap Heparin HP column (Fig. 1A and table S1). Analysis of purified complexes by negative-stain electron microscopy confirmed the presence of rod-shaped cohesin holocomplexes, the majority in a folded conformation (Fig. 1B) (23). The Scc2-Scc4 complex was also purified from budding yeast (Fig. 1C) using a similar strategy and showed DNA binding activity as expected (fig. S1A) (21, 22). Purified cohesin also bound plasmid DNA in a salt-resistant manner (fig. S1B), and the bound plasmid was released by DNA cleavage with restriction enzymes (fig. S1C). This is consistent with the topological binding mode proposed for this complex (18, 22). However, in our hands, this activity was not strictly dependent on ATP and was not stimulated by Scc2-Scc4 (fig. S1B), in contrast to what has been reported recently (18, 22). Last, we confirmed that our purified Scc2-Scc4 complex was able to stimulate cohesin ATPase activity (Fig. 1D) (21, 22).

(A) Purified cohesin tetramer containing Smc1, Smc3, Scc1, and Scc3 was analyzed by SDSpolyacrylamide gel electrophoresis (PAGE) followed by Coomassie blue staining. Western blot analysis shows the mobility of Smc1 and Scc1. (B) Top panel: Representative micrograph of a BS3-crosslinked cohesin sample observed in negative stain EM. Scale bar, 50 nm. Bottom panel: Class averages obtained with RELION. A set of the best ~5000 particles was used for this classification. The size of the circular mask is 450 . (C) Coomassie blue staining of the purified Scc2-Scc4 complex. (D) ATP hydrolysis by yeast cohesin and cohesin ATPase mutant Smc3-K38I with or without the Scc2-Scc4 complex.

Next, we sought to test whether budding yeast cohesin exhibited the behavior described for cohesin from other organisms on DNA curtains (1517). -DNA molecules (48.5 kb) were anchored to a lipid bilayer in a flow cell surface and aligned into double-tethered DNA curtains using nanofabricated barriers (Fig. 2A) (15). Quantum dots (Qdots) conjugated to antibodies against the hemagglutinin tag (HA3) fused to the C-terminal region of the Scc1 kleisin subunit were used to visualize the complexes (Fig. 2B). On flowing the labeled cohesin complex over the DNA curtains, binding was observed at low ionic strength (Fig. 2A). The chamber was flushed with a high ionic strength buffer to remove nontopologically bound complexes (Fig. 2A). While a large fraction of cohesin complexes dissociated, we observed diffusion along the DNA (Fig. 2B). The binding preference of cohesin to more A/T-rich regions reported earlier (15) was also observed (Fig. 2, C to E). The diffusion coefficients correlated with the ionic strength of the buffer (fig. S2F). The survival probabilities of cohesin were not affected by the addition of ATP, or the ATP analogs adenosine 5-diphosphate (ADP) and ATPS (Fig. 2C). We found that the presence of Scc2-Scc4 enhanced the ability of cohesin to stay bound on the DNA (Fig. 2D); however, the presence of nucleotides did not alter cohesin stabilities (Fig. 2D). Therefore, these results are consistent with the activities observed for cohesin from other organisms (15, 17) and show that budding yeast cohesin undergoes rapid diffusion on DNA curtains in an ATP-independent manner.

(A) Schematic representation of double-tethered DNA curtains used in the study. (B) Image of cohesin tagged with quantum dots (magenta) bound to -DNA stained with YOYO-1 (green). Scale bar, 10 m. (C) Survival probability plots of cohesin in the presence of ATP, ADP, ATPS, or no nucleotide. (D) Lifetimes of cohesin (fast phase and slow phase) in the presence or absence of Scc2-Scc4 and different ATP analogs. Error bars are 68% confidence intervals from bootstrapping. (E) Image of a pair of double-tethered DNA curtains bound by cohesin. DNA molecules are in green, and cohesin is in magenta. Diagrammatic representation is shown (left). (F) Time-lapse images of a pair of double-tethered DNA curtains bound by cohesin as they are tethered. DNA molecules are in green, and cohesin is in magenta. Diagrammatic representation is shown (top). Pairing events were observed frequently in the DNA curtains. An average of 5 to 10 events per DNA curtain was detected.

In our DNA curtain experiments, we made an observation not reported in earlier studies (15, 17). Cohesin signals were often observed bound between what appeared to be two fused DNAs (Fig. 2E). The pairing events formed under low-salt conditions in the presence of ATP (Fig. 2F and movies S1 and S2), but they persisted when the chamber was flushed with a high ionic strength buffer, raising the possibility that topologically bound complexes mediated these events.

To further explore our observation that cohesin tetramers paired -DNA molecules on the DNA curtains, we decided to use a dual-trap optical tweezer with confocal fluorescence microscopy capabilities. A similar approach has been previously used in the study of protein-DNA interactions (24). Briefly, we tether a -DNA molecule with biotinylated ends to two optically trapped streptavidin-coated polystyrene beads, enabling us to accurately apply and measure forces on the captured DNA molecule. We performed our experiments in multichannel laminar flow cells where we had the possibility to move the tethered DNA to different flow lanes containing different protein complexes and buffers. In addition, we were able to image the tethered DNAs using confocal fluorescence microscopy. Overall, the approach allows increased experimental control over DNA curtains. Proteins can be added, removed, or incubated under different salt conditions sequentially, and the physical effect of their activities can be measured accurately on a single DNA molecule.

To test for the formation of intramolecular cohesin bridges in cis, we adapted a previously published protocol that measures protein-mediated DNA bridging (Fig. 3A) (25, 26). First, we captured a single -DNA molecule and generated a force-extension (FE) curve in the absence of protein by extending the molecule slightly beyond its contour length (~16 m). We then moved the DNA to a channel containing 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP in 50 mM NaCl and incubated for 30 s in a relaxed conformation (~3 m between beads). Following incubation, the relaxed DNA was then moved to a channel without protein but containing 1 mM ATP in 125 mM NaCl. Reextending the DNA in the buffer-only channel yielded FE curves with sawtooth features at extensions shorter than the contour length (Fig. 3B, Cohesin + Scc2/4). This is characteristic of intramolecular bridge rupture events (25, 26) (Fig. 3A, right) and shows that cohesin can tether the DNA in cis forming a protein-mediated bridge between different segments of the molecule, thus creating an intramolecular loop. When we repeated this protocol in the presence of 1 nM cohesin and no Scc2-Scc4 (Fig. 3B, Cohesin), or 2.5 nM Scc2-Scc4 and no cohesin (Fig. 3B, Scc2/4), FE curves identical to those of the initial naked DNA were observed, demonstrating that no protein-mediated bridges were formed (Fig. 3A, left). Similarly, incubating 1 nM cohesin and 2.5 nM Scc2-Scc4 complex in the absence of ATP, or with the ATP analogs ADP or ATPS, yielded FE curves identical to those of naked DNA (fig. S3A). To confirm the requirement of ATP, we repeated the protocol in the presence of 1 nM cohesin ATPase mutant (K38I) (fig. S4) and 2.5 nM Scc2-Scc4 (Fig. 3B, CohesinK38I + Scc2/4). FE curves identical to those of the naked DNA were observed (Fig. 3B, CohesinK38I + Scc2/4). Therefore, the DNA bridging activity requires ATP and depends on the Scc2-Scc4 loader complex.

(A) Schematic representation of FE curve for -DNA exhibiting the presence (right diagram and graph) and absence (left diagram and graph) of protein DNA bridges. Dotted line is fit to worm-like chain for naked DNA. (B) FE curves for -DNAs preincubated with 1 nM cohesin and 2.5 nM Scc2-Scc4 complex and 1 mM ATP (Cohesin + Scc2/4), 1 nM cohesin and 1 mM ATP (Cohesin), 2.5 nM Scc2-Scc4 complex and 1 mM ATP (Scc2/4), or 1 nM cohesin ATPase mutant and 2.5 nM Scc2-Scc4 complex and 1 mM ATP (CohesinK38I + Scc2/4). Schematic diagram of the experimental design. After capturing a single DNA molecule between two optically trapped beads, DNA was incubated in the presence of protein in a relaxed conformation (3-m bead distance) for 30 s in 50 mM NaCl and then moved to a buffer channel with 125 mM NaCl for extension and measurements. Only incubation with 1 nM cohesin and 2.5 nM Scc2-Scc4 complex and 1 mM ATP (Cohesin + Scc2/4) showed DNA bridging rupture events. (C) FE curves in the presence of increasing ionic strength. High salt favors topologically constrained and permanent DNA bridges. (D) Schematic representation of the experimental design to test cohesin second DNA capture. After capture of -DNA between the two optically trapped beads, DNA is extended and incubated for 30 s in the protein channel. DNA is moved to a buffer channel and then relaxed (3-m bead distance) and incubated for 30 s before reextension to test for DNA bridges (E). The extended DNA is then incubated in a relaxed position in the protein channel and then moved to buffer channel and extended to confirm that bridges can be formed when protein is loaded while DNA is relaxed (F). (E) -DNA incubated with 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP in an extended conformation and then moved to a buffer channel (125 mM NaCl) in the presence of 1 mM ATP (buffer only, dark blue) or 2.5 nM Scc2-Scc4 complex and 1 mM ATP (+Scc2/4, light blue). DNAs were reextended, and the FE curves were recorded. (F) The -DNA molecules in (E) were incubated in a relaxed position (3-m bead distance) in the presence of 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP DNAs. DNAs were moved to a buffer-only channel (125 mM NaCl containing 1 mM ATP) and reextended. FE curves show the presence of DNA bridging rupture events.

Next, we tested the effect of ionic strength on cohesin bridging (Fig. 3C). Cohesin bridges were observed at all salt concentrations tested (Fig. 3C). The length of DNA extension released during the rupture of a DNA bridge can be directly related to the loop size encompassed by the bridge. We analyzed the sizes of the DNA bridges from the FE curves at 125 mM salt (fig. S3B) and found that the distribution of loop sizes is exponential with a characteristic size of ~900 base pairs (bp), consistent with a model of random bridge formation (5, 6). Most of the small sawtooth peaks observed at low forces and extensions disappear under high-salt conditions, while the overall contour length of the DNA remained reduced (Fig. 3C). We also recorded FE curves when we relaxed tethers (Fig. 3, B and C, reverse arrows) after the extensions are done in the buffer channel, therefore in the absence of protein (Fig. 3, B and C, forward arrows). These showed that compaction due to DNA bridges formed at low-salt concentrations was lost after extension (Fig. 3C, reverse arrows; 50 mM NaCl) with force. However, relaxation of tethers with DNA bridges formed at high-salt concentrations showed compaction events that had resisted after extension (Fig. 3C, reverse arrows; 300 and 500 mM NaCl). These results show two distinct types of cohesin bridging events: (i) one predominantly occurring at low salt that is characterized by frequent interactions that are reversible and can be disrupted by moderate force (5 to 40 pN) and (ii) a second permanent bridge class that resists higher ionic strength conditions and full physical stretching of the DNA molecule. Both classes of DNA bridges were not observed when an ATPase mutant cohesin complex (SMC3-K38I) was used (Fig. 3B, CohesinK38I + Scc2/4), confirming that the ATPase activity of the complex is a requirement for both types of bridges. Next, we tested whether permanent bridges could resist repeated extensions. We performed two cycles of bead extension and relaxation and confirmed the persistence of the permanent cohesin bridge using FE curves (fig. S5). We conclude that permanent cohesin bridges resist high stretching forces and that the complexes mediating the tethers cannot be displaced from the DNA molecules. This explains the repeated detection of the same bridge on FE curves during the cycle of bead extension and relaxation (fig. S5).

Recent studies using purified cohesin from Schizosaccharomyces pombe have shown that cohesin can capture a second DNA, but only if single stranded (14). This led the authors to conclude that cohesin is not capable of trapping to dsDNAs in vitro (14). Moreover, it was suggested that this activity is likely to occur at replication forks, where cohesin bound to a dsDNA molecule is exposed to nascent ssDNA (14). The second capture of the single-stranded molecule was dependent on the presence of cohesin loader and ATP (14). Our results seem to contradict this because we show that cohesin purified from Saccharomyces cerevisiae is fully able to trap two dsDNA molecules (Fig. 3, B and C). Next, we decided to investigate whether capture of the two molecules is sequential or simultaneous. In our original tethering assay, we could not differentiate whether the two dsDNAs are captured sequentially or in a single step, as we had incubated the DNA in a relaxed position (with the two DNA segments in proximity). To distinguish whether one or two events were involved in the formation of the cohesin tethers observed, we sought to test whether cohesin could capture a second DNA after initial loading. To this aim, we captured a single -DNA molecule and generated an FE curve. We maintained the DNA in an extended position (~15 m between beads) using a pulling force of 5 pN (Fig. 3D) and loaded cohesin by moving the DNA to a channel containing 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP in 50 mM NaCl. We incubated the DNA for 30 s (Fig. 3D) before moving it to a different channel containing 1 mM ATP in 125 mM NaCl. We then relaxed the DNA conformation (~3 m between beads) to allow DNA segments to come into proximity (Fig. 3D) and incubated in the relaxed conformation for an additional 30 s. The FE curve obtained after reextension of the DNA was identical to the initial naked DNA profile (Fig. 3E, Only buffer, and fig. S6). We obtained a similar result when we included 2.5 nM Scc2-Scc4 complex and 1 mM ATP in the channel where we relaxed the DNA (Fig. 3E, +Scc2/4, and fig. S6). These results show that loaded cohesin is unable to capture a second DNA segment. To confirm that DNA bridges could be formed in the same DNA in one step, we relaxed the molecules used in the experiments and incubated them for 30 s in a channel containing 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP. When molecules were reextended, the resulting FE curves confirmed the formation of DNA bridges (Fig. 3F and fig. S6). In addition, we confirmed that cohesin complexes can bind to extended DNAs using a published DNA friction protocol (fig. S7) (27). Therefore, our results are consistent with a previous report (14), showing that cohesin bound to DNA cannot undergo a second capture event involving a dsDNA molecule, but demonstrate that cohesin is able to capture two dsDNAs simultaneously. A previous study could not evaluate the possibility that cohesin could capture two dsDNAs simultaneously, thus reaching an erroneous conclusion (14). We conclude that cohesin establishes bridges between two dsDNA in a single step, or two kinetically very close steps, which requires physical proximity of the DNA segments.

Next, we investigated whether cohesin can form intermolecular bridges. We developed an intermolecular bridging assay, where two dsDNA molecules are tethered in parallel between the pair of beads, and tested the ability of cohesin to form bridges between these two molecules (Fig. 4A). DNA molecules were visualized with SYTOX Orange. After confirming the presence of two DNA molecules tethered in parallel between the beads (Fig. 4B, Naked), the DNA was incubated in a relaxed state to bring the DNAs into proximity (~3-m bead distance) in the presence of 1 nM cohesin and 2.5 nM Scc2-Scc4 and 1 mM ATP for 30 s. The DNAs were moved to a buffer-only channel (300 mM NaCl plus 1 mM ATP). Strikingly, clear bridging was observed between the two molecules on reextension (Fig. 4B, Cohesin + Scc2/4). DNA bridges did not form in the absence of ATP (Fig. 3B, no ATP) or when we used cohesin ATPase mutant complex (Fig. 4B, K38I + Scc2/4), confirming that cohesins ATPase activity is required. Bridge formation in this assay was very efficient; of 10 molecules tested, 8 showed intermolecular bridges (Fig. 4B, Cohesin + Scc2/4) and 2 showed intramolecular bridging on the two individual DNAs. Intermolecular bridges always appeared to be near the midpoint of the DNA (Fig. 4B, Cohesin + Scc2/4). Potential reasons to explain this include the fact that the central region of -DNA molecules is rich in A/T content where cohesin might bind preferentially. Alternatively, cohesin might be able to slide on the DNA while maintaining tethers and therefore likely to move to the center regions as the molecules are extended. To further characterize this, we used a quadruple-trap optical tweezer setup, which allows the independent manipulation of the two DNA molecules (27).

(A) Schematic representation of the experimental design for the dual-trap optical tweezer to generate permanent intermolecular cohesin bridges. Two -DNA molecules are tethered between the two beads and incubated in a relaxed position (3-m bead distance) in the presence or absence of protein in buffer containing 50 mM NaCl. The relaxed molecules are then moved to a different channel containing 300 mM NaCl and reextended. Imaging is done before incubations and after reextension in a buffer containing 300 mM NaCl and 50 nM SYTOX Orange to visualize DNA. (B) Two -DNA molecules were tethered and treated as described in (A) and incubated with either (i) 1 nM cohesin, 2.5 nM Scc2-Scc4, and no ATP (Cohesin + Scc2/4, left); (ii) 1 nM cohesin, 2.5 nM Scc2-Scc4, and 1 mM ATP (Cohesin + Scc2/4, middle); or (iii) 1 nM cohesin ATPase mutant K38I, 2.5 nM Scc2-Scc4, and 1 mM ATP (K38I + Scc2/4, right). Imaging was performed before incubation and after DNA reextension in a buffer containing 300 mM NaCl to minimize DNA entanglement and 50 nM SYTOX Orange to visualize DNA. Images from three independent experiments are shown. Three independent experiments are shown for each category. (C) Schematic representation of the experimental design to test for sliding of permanent cohesin bridges (top diagram). Following the formation of an intermolecular cohesin bridge (see fig. S8 for details in bridge formation protocol), beads 3 and 4 were moved together in the x axis to slide the bridge along DNA1. Images showing two representative sliding experiments are shown. Experiments were performed in a buffer containing 300 mM NaCl and 50 nM SYTOX Orange. Movies of the experiments are shown in movies S4 and S5. The experiment was performed three times, and sliding was observed in all cases. (D) Schematic representation of the experimental design to disrupt intermolecular cohesin bridges. Following the formation of an intermolecular cohesin bridge, bead 3 is moved down in the y axis until one of the DNA ends loses contact with the bead. Imaging was performed before and after the pull in a buffer containing 300 mM NaCl and 50 nM SYTOX Orange. Representative experiment is shown. A movie of the experiment is shown in movie S6.

We first captured two single -DNA molecules using a pair of traps for each (DNA1 between traps 1 and 2 and DNA2 between traps 3 and 4) in a parallel conformation (fig. S8). Both DNA molecules were stretched close to their contour lengths (~16 m). We then manipulated DNA2 using beads 3 and 4 and moved it upward (in the z direction) before rotating it 90 and moving it into a crossed conformation directly above DNA1 (fig. S8). We then lowered DNA2 to its original z position and relaxed it to ensure physical contact between the two DNA molecules at the junction point (fig. S8). We then moved the crossed DNAs into a different channel containing 1 nM cohesin, 2.5 nM Scc2-Scc4, and 1 mM ATP (60 s, 50 mM NaCl) before returning the DNAs to a channel containing 1 mM ATP in 300 mM NaCl. We reversed the manipulation of DNA2, first moving bead 3 upward and over DNA1 before manipulating beads 3 and 4 so that DNA2 was rotated 90 and lowered back to the original position where DNA1 and DNA2 were parallel to each other. When we moved the beads to a channel containing SYTOX Orange to visualize DNA, we observed that DNA1 and DNA2 were bridged (fig. S8), as expected from our analysis of parallel DNA bridging in the dual-trap optical tweezers setup (Fig. 4B, Cohesin + Scc2/4 + 1 mM ATP). We then tested whether simultaneously moving DNA2 using beads 3 and 4 in the x axis would cause the sliding of the bridge along DNA1 (Fig. 4C). We observed that the bridge could be moved, showing that cohesin can slide on DNAs while tethering two DNA molecules in trans (Fig. 4C and movies S4 and S5). When we applied force to disrupt the bridge [moving bead 3 down in the y axis (away from beads 1 and 2); Fig. 4D], we were not able to break apart the cohesin tether. At high forces, the interaction between the ends of the DNAs and the beads often snapped (Fig. 4D and movie S6). Amazingly, cohesin bridges resisted this, and half of DNA2 could be observed hanging from the bridge (Fig. 4D and movie S6). We conclude that permanent intermolecular cohesin bridges can slide on DNA and resist high force. We predict that the forces exerted to disrupt the interaction between the DNAs and the bead exceed 80 pN. At these high forces, the prediction is that all the protein interfaces on cohesin rings should be disrupted. Therefore, cohesin association with DNA in permanent tethers is likely to occur in a manner that resists opening of the interfaces.

Previous studies using purified cohesin from different organisms did not report DNA bridging activities (1517); however, the studies did not use budding yeast cohesin. We therefore decided to test whether the bridging activity observed is specific for S. cerevisiae cohesin tetramers or it has been conserved in cohesin from other organisms. To this aim, we purified the human cohesin (hCohesin) tetramer complex, containing hSmc1, hSmc3, hRad21, and Stag1, as described previously (fig. S9A) (28). We then tested whether hCohesin could bridge DNA intramolecularly. We captured a single -DNA molecule and generated an FE curve in the absence of protein to confirm the presence of naked DNA. We then moved the DNA to a channel containing 1 nM hCohesin and 1 mM ATP in 50 mM NaCl and incubated it for 30 s in a relaxed conformation (~3 m between beads). We then moved the relaxed DNA to a channel without protein in the presence of 1 mM ATP in 125 mM NaCl. Reextending the DNA resulted in FE curves with a naked DNA profile (Fig. 5A, hCohesin), demonstrating that hCohesin on its own cannot promote DNA bridges. Although we could not obtain hScc2-Scc4, we decided to test whether the budding yeast loader complex Scc2-Scc4 (scScc2-Scc4) had any effect on hCohesin activity. To this aim, we repeated the intramolecular DNA bridging assays with hCohesin and included the Scc2-Scc4 loader complex in the incubations. Relaxed DNA was incubated in the presence of 1 nM hCohesin tetramer, 2.5 nM scScc2-Scc4 complex, and 1 mM ATP in 50 mM NaCl. The relaxed DNA was then moved to a channel with 1 mM ATP in 125 mM NaCl. Reextension yielded the sawtooth features characteristic of intramolecular bridge rupture events (Fig. 5B, hCohesin + Scc2/4) detected with yeast cohesin tetramers (Fig. 3C, 125 mM). Therefore, hCohesin tetramers containing Stag1 have conserved the ability to bridge DNA. hCohesin was able to form both reversible and permanent bridges (Fig. 4B, hCohesin + Scc2/4).

(A) FE curve for -DNA preincubated with 1 nM human cohesin and 1 mM ATP in 125 mM NaCl buffer (hCohesin). Dotted line is fit to worm-like chain model. After capturing a single DNA molecule between two optically trapped beads, DNA was incubated in the presence of protein in 50 mM NaCl buffer in a relaxed conformation (3-m bead distance) for 30 s and then moved to the 125 mM NaCl buffer channel for extension and measurements. No evidence of DNA bridges was observed under this condition. (B) FE curve for -DNA preincubated with 1 nM human cohesin, 2.5 nM yeast Scc2-Scc4, and 1 mM ATP in 125 mM NaCl buffer (hCohesin + Scc2/4). Experimental procedure as in (A). FE curves exhibited multiple rupture events indicating the presence of reversible and permanent DNA bridges. (C) DNA compaction trace for -DNA molecule extended using a force of 1 pN (top). The DNA was tethered between two beads. One bead was clamped (fixed), while a 1-pN force was applied to the second bead to maintain the molecule extended. The DNA was then incubated in the presence of 1 nM condensin (1 mM ATP in 50 mM NaCl) (left, magenta trace). The FE curve for the -DNA full extension after incubation is shown (bottom). Additional examples can be found in fig. S10. (D) DNA compaction trace for -DNA molecule extended using a force of 1 pN (top) in the presence of 1 nM cohesin and 2.5 nM Scc2-Scc4 complex (1 mM ATP in 50 mM NaCl) (right, yellow trace). The distance between the beads was recorded over time. The FE curve for the -DNA full extension after incubation is shown (bottom). Additional examples can be found in fig. S10. (E) Kymograms of single-tethered -DNA stained with (YOYO-1) during the incubation with yeast cohesin and Scc2-Scc4 in the presence of ATP in 50 mM NaCl buffer at a flow rate of 20 l/min. HF, high flow. The free end of DNA is marked with orange arrowheads. No compaction of single-tethered -DNAs was observed. (F) Kymograms of single-tethered -DNA stained with (YOYO-1) during the incubation with yeast cohesin and Scc2-Scc4 in the presence of ATP in 50 mM NaCl buffer at a flow rate of 10 l/min. The conditions are as in (E) except for the reduced flow rate. Slow compaction of single-tethered -DNAs was observed over time (orange arrowheads mark the free end of DNA). (G) Kymograms of single-tethered -DNA stained with (YOYO-1) during the incubation with yeast cohesin and Scc2-Scc4 in the presence of ATP in 50 mM NaCl buffer at stopped flow. The free end of DNA is marked with orange arrowheads. The HF phase at the end of the experiment shows that the DNA was compacted during the stopped flow phase. Note that under stopped flow conditions, DNA molecules that diffuse laterally on the flow chip can transiently cross the field of view and also appear in a kymogram representation. Examples are marked with asterisks (*). These events bear no relevance for the interpretations of the assay.

Besides mediating sister chromatid cohesion (1, 2), cohesin holds individual chromatids in cis, thus forming loops (4, 29, 30). Recently, yeast condensin was the first SMC complex shown to exhibit an activity compatible with loop extrusion (7). It is unclear whether this activity is also present in the other eukaryotic SMC complexes cohesin and Smc5/6. Condensin can compact linear DNA against forces of up to 2 pN (19). However, condensin loop extrusion activity is only observed when DNA is stretched under significantly lower forces (below 0.5 pN) (7). We purified yeast condensin (fig. S9, B and C) using an established protocol (20, 31) and tested whether, as predicted from studies using magnetic tweezers (19), it could also compact -DNA molecules extended in the optical tweezers against a force of 1 pN. A single -DNA molecule was first captured between the beads. We then immobilized one of the beads and applied a constant force of 1 pN to the other bead in the opposite direction. This maintains the DNA extended with ~14 m between beads. We then moved the DNA to a channel containing 1 nM condensin in 50 mM NaCl buffer supplemented with 1 mM ATP. We incubated the extended DNA recording the distance between the two beads over time (Fig. 5C, Condensin). We observed progressive decrease of the distance between the beads (Fig. 5C, Condensin, and fig. S10), consistent with the activity of condensin as a motor that compacts DNA (19). Some condensation events occurred in short bursts and caused the molecule to shorten ~1 to 2 m in a few seconds (Fig. 5C, Condensin, and fig. S10). After incubation, we generated an FE curve, which showed the presence of sawtooth peaks characteristic of protein-mediated DNA bridging (Fig. 5C, bottom) (25, 26). Condensin bridges were fully reversible and disappeared when the DNA was extended (Fig. 5C, bottom). It is unclear whether the compaction observed is due to loop extrusion because this activity was reported to occur at forces below 1 pN (7). Next, we sought to text whether yeast cohesin tetramers could also compact extended -DNA molecules in this assay. We incubated the DNA extended using 1 pN of force with 1 nM cohesin, 2.5 nM Scc2-Scc4 complex, and 1 mM ATP in 50 mM NaCl buffer and incubated the extended DNA recording the distance between the two beads (Fig. 5D, Cohesin). The distance between the beads did not change over time (Fig. 5D, Cohesin, and fig. S10); therefore, we conclude that cohesin tetramers do not exhibit DNA compaction activity in this assay. As expected, the FE curve generated after incubation showed no evidence of protein-mediated DNA bridging (Fig. 5D, bottom), and similar results were obtained when we used a stretching force of 0.5 pN.

Since loop extrusion activity of condensin occurs at forces below 0.5 pN (7), we considered the possibility that yeast cohesin might also be able to extrude loops (and hence condense DNA) at extremely low forces. Below 0.5 pN, our optical tweezer did not reliably maintain the distance between the beads (data not shown). We therefore used single-tethered DNA curtains and different flow rates to extend DNA at very low tensions. Initially, we incubated cohesin in the presence of Scc2/Scc4 and ATP using a 125 mM NaCl buffer and a flow rate of 30 l/min; however, we did not observe compaction of single-tethered DNAs (data not shown). We then decided to reduce the ionic strength of the buffer to 50 mM NaCl and the flow rate to 20 l/min (Fig. 5E). We did not observe compaction in the course of the experiment (Fig. 5E). However, when we further reduced the flow rate to 10 l/min we observed slow compaction of the majority of the molecules (Fig. 5F). Last, we performed the same experiment but stopped the flow after protein injection (Fig. 5G). We observed rapid compaction of the single-tethered DNAs (Fig. 5G). From these data, we conclude that DNA compaction in single-tethered DNA curtains at such low flow is likely to be formed as a consequence of compaction that might involve loop extrusion since this activity only occurs at low ionic strength conditions and when DNA is extended by very low force.

The original role attributed to cohesin was the maintenance of sister chromatid cohesion from S phase until the anaphase onset (1, 2). Here, we have developed powerful single-molecule assays to probe the mechanisms by which cohesin holds DNAs together. Using them, we have shown that cohesin complexes can form different types of bridges between dsDNAs and that this requires Scc2-Scc4 and ATP. The two classes of cohesin tethers exhibited different physical properties, particularly the sensitivity to being broken by force. The reversible bridges were disrupted when moderate forces (5 to 40 pN) were applied (Fig. 3C). In contrast, permanent bridges could withstand extreme forces without being disrupted (Figs. 3C and 4D). They are also more predominant in high ionic strength conditions (Fig. 3C). On the basis of these physical properties, we propose that permanent bridges represent cohesin complexes that maintain sister chromatid cohesion. However, further characterization of their genesis, architecture, and biochemistry will be important to confirm such proposal. Reversible bridges were more predominant at low-salt concentrations (Fig. 3C), which suggest that they are likely formed by protein-protein interactions. In low salt, cohesin is likely to be saturated on DNA and being relatively sticky could easily engage in nonspecific interactions. Therefore, some reversible bridging events could potentially represent nonspecific protein aggregation. In particular, this might be the case for intramolecular DNA bridging at 50 mM NaCl salt (Fig. 3C). However, even under these conditions, reversible bridges were ATP and Scc2/4 dependent (fig. S3A). At 125 mM NaCl salt, which is in the physiological range, reversible bridges were also significant and resisted forces of up to 40 pN (Fig. 3C), strongly arguing that reversible bridges are biologically relevant. Previous studies have demonstrated that cohesin can use nontopological mechanisms (32); in addition, interallelic complementation between different cohesin alleles has also been reported (33). It is therefore possible that reversible DNA bridges reflect functional cohesin-cohesin interactions.

Recent studies have interrogated cohesin mechanisms using biochemical reconstitution of topological loading onto plasmids (14, 18, 34, 35). We believe that the single-molecule assay presented in this study is more informative for the study of cohesin bridging. In our hands, cohesin loading in the gel-based assay was not strictly ATP dependent and was not stimulated by Scc2/4, as observed for S. pombe cohesin (14, 18, 34, 35). Topological loading efficiency can be dependent on multiple factors, but critically on the amount of protein used, the times of incubation, and the number and stringency of the washes. We followed the original protocol described for S. pombe cohesin (18), and despite attempting different conditions, we never observed ATP-dependent loading. It is therefore likely that S. pombe and S. cerevisiae cohesins behave differently. The observation that S. pombe cohesin does not show bridging activity in double-tethered DNA curtains (15), while S. cerevisiae cohesin does (Fig. 2, E and F), supports this possibility.

Our results using two DNA molecules demonstrate that permanent cohesin tethers can slide when force is applied (Fig. 4C); however, when the permanent bridges occur in cis, cohesin complexes cannot slide off the DNA molecules (Fig. 3C and fig. S5). The simplest explanation is that the two DNA molecules tethered are not located in the same physical space within the protein (Fig. 6A). The two main models proposed to explain how cohesin holds sister chromatids are the ring and handcuff models. The basic difference between these two models is the fact that in the ring model, the two DNAs occupy the same physical space within cohesin, i.e., they are co-entrapped in one compartment of the cohesin structure (10, 11), while in the handcuff model (and all its variations), the two DNAs are located in different physical compartments (1, 12, 13), generally argued to be two separate (but interacting) complexes. On the basis of the single-ring model, it would be expected that cohesin slides off DNA molecules when bridging them intramolecularly (Fig. 6A). In contrast, our observations suggest that this is not the case (Fig. 3C). Using in vivo cysteine cross-linking of trimer cohesin complexes, it has been recently shown that cohesin has different subcompartments (36). Sister DNAs occupied the K (kleisin) compartment formed between the SMC ATPase heads and the Scc1 subunit (36). Scc3 and Scc1 form a module that binds DNA and is necessary for cohesin association to chromosomes (37), but Scc3 was not crosslinked in the subcompartment study (36). We propose that DNAs in permanent cohesin bridges might be held in two chambers of the K (kleisin) compartment (Fig. 6B, K1 and K2), physically separated by Scc3 (Fig. 6B), and the architecture would resemble a pretzel-like structure (Fig. 6B). The DNAs might be separated (one in K1 and the other in K2), or might travel through the two K compartments together. Alternatively, different compartments of two cohesin complexes might be involved (Fig. 6C).

(A) Schematic representation of expected behavior of intramolecular cohesin tethers from the previously proposed ring model. The model proposes that cohesin co-entraps two DNAs within its ring structure, i.e., both DNAs occupy one physical space within cohesin. From this model, it is expected that cohesin should be fully displaced from -DNA molecules when tethering in cis as force is applied to separate the beads. This is not what it was observed experimentally (Fig. 3C and fig. S5). (B) Schematic representation of expected behavior of intramolecular cohesin tethers from the subcompartment model. The subcompartment model is based on the assumption that DNAs are located in different physical compartments. The prediction from the model is that cohesin cannot be fully displaced from -DNA molecules when tethering them in cis. This is what we observed experimentally (Fig. 3C and fig. S5). (C) Proposed model for a single cohesin complex with at least three subcompartments (cohesin pretzel). In this model, sister DNAs occupy two different chambers (K1 and K2) of the K (kleisin) compartment formed between the SMC ATPase heads and the Scc1 subunit (36). Two possible conformations of SMC hinges are shown. Note that the experimental data are also compatible with the possibility that both DNAs jointly travel through the two chambers (K1 and K2) of the K compartment. (D) Schematic representation of previously proposed cohesin handcuffs models holding sister DNAs in different compartments of two separate complexes, which also fits with our experimental observations.

Kimura et al. (5) first proposed that the SMC complex condensin might generate DNA loops (5). This was conceived as one of two models that could explain how condensin specifically produced (+) trefoil knots in the presence of a type II topoisomerase (5). The proposal was based on an earlier model of loop expansion that was put forward for bacterial MutS action (38). MutS loop expansion was shown to occur as a consequence of ATP-dependent bidirectional movement of the MutS dimer from the initial loading site (38). The proposal of Kimura et al. (5) has been recently demonstrated directly through the observation of condensin-dependent DNA looplike structures on surface-tethered, flow-stretched DNA (7). The loop extrusion activity of cohesin was also conceived as a model that could explain the role of cohesin in genome folding through cis looping and the preferential use of convergent CTCF DNA motifs at TAD borders (8, 9). We detected DNA compaction by yeast cohesin tetramers at very low flow rates (Fig. 5, F and G), as would be predicted from a loop extrusion activity similar to the one shown for condensin (7). HiC data show that removal of cohesin leads to loss of contacts at TAD boundaries (6, 8, 39), demonstrating that the complex is involved in the formation or maintenance of loops. It is likely that cohesin extrudes DNA loops in a similar manner to condensin (7). However, our data, although consistent with cohesin function as a loop extruder, do not demonstrate it. We would like to note that our data showing intramolecular tethering by cohesin do not imply that cohesin generates loops in vivo through random DNA bridging. We feel that this would be highly unlikely. The intramolecular tethers observed might reflect an in vitro activity (as cohesin is unlikely to differentiate between cis and trans tethering when loaded onto DNA in these assays). Further experiments will be required to test whether intramolecular tethering is of any relevance in vivo. The activities described here are fully consistent with the original role attributed to cohesin in maintaining sister chromatid cohesion (1, 2). Our work provides a new critical tool for future investigations to further decipher how cohesin executes one of the critical functions required for genome inheritance, i.e., maintaining sister chromatids in close proximity from the time they are born in S phase until they are separated in anaphase.

The different subunits of the S. cerevisiae Scc2-Scc4 and cohesin complexes were synthesized under the control of galactose-inducible promoters and cloned into multicopy episomal vectors (URA3-SCC4-GAL1-10promoter-SCC2-3xmyc-3xStrepII;TRP1-SMC1-3xStrepII-GAL1-10promoter-SMC3 GAL7promoter-MCD1-8xHis-3xHA; URA3-GAL1-10promoter-SCC3). Yeast W303-1a strains carrying the different constructs (CCG14800 for the Scc2-Scc4 complex, CCG14801 for cohesin tetramer, and CCG14815 for cohesin smc3-K38I tetramer) were grown at 30C in selective dropout medium containing 2% raffinose and 0.1% glucose to an OD600 (optical density at 600 nm) of 1. Protein expression was induced by addition of 2% galactose, and cells were grown for further 16 hours at 20C. Cells were then harvested by centrifugation at 4C, resuspended in two volumes of buffer A [25 mM Hepes (pH 7.5), 200 mM NaCl, 5% glycerol, 5 mM -mercaptoethanol] containing 1 cOmplete EDTA-free protease inhibitor mix (Roche), frozen in liquid nitrogen, and lysed in Freezer-Mill (SPEX CertiPrep 6870). Cell powder was thawed at 4C for 2 hours before mixing it with one volume of buffer A containing benzonase (Millipore) and incubated at 4C for an extra hour. Cell lysates were clarified by centrifugation at 45,000g for 1 hour followed by filtration using 0.22-m syringe filters. Clarified lysates were loaded onto 5-ml StrepTrap-HP columns (GE Healthcare) preequilibrated with buffer A. The resin was washed with five column volumes of buffer A and eluted with buffer B (buffer A containing 5 mM desthiobiotin). The peak fractions containing the overexpressed proteins were pooled together, and salt concentration was adjusted to 150 mM NaCl using 100 mM NaCl buffer A. Samples were then filtered as described above to remove residual aggregates and loaded onto 5-ml HiTrap Heparin HP (GE Healthcare) columns preequilibrated with 150 mM NaCl buffer A. Elution was carried out using a linear gradient from 150 mM to 1 M NaCl in buffer A. Peak fractions were pooled and concentrated by centrifugal ultrafiltration (100 kDa Amicon Ultra, Millipore). Salt concentration was adjusted to 300 mM NaCl during the concentration step. Gel filtration was carried out using a Superose 6 Increase 100/300 GL column (GE Healthcare) in 300 mM NaCl buffer A. Fractions corresponding to monomeric complexes were pooled and concentrated as described above. Purified proteins were analyzed by SDS-PAGE (NuPAGE 4 to 12% bis-tris protein gels, Thermo Fisher Scientific) and Coomassie staining (InstantBlue, Expedeon). Protein identification was carried out by mass spectrometry analysis and Western blot. S. cerevisiae condensin complex was expressed and purified, as previously described (20, 31).

Human cohesin tetramer was purified, as described before (28). Human cohesin subunits (RAD21, SMC1A, SMC3-FLAG, 10xHis-SA1) were coexpressed in High Five insect (BTI-Tn-5B1-4) cells. Cells were disrupted by short sonication. Afterwards, the lysate was clarified by high-speed centrifugation. The complex was then purified via HisTrap [washing buffer: 25 mM tris (pH 7.5), 500 mM NaCl, 5% glycerol, 2 mM MgCl2, 20 mM imidazole, 0.01% Tween-20, 20 mM -mercaptoethanol; elution buffer: 25 mM tris (pH 7.5), 150 mM NaCl, 5% glycerol, 2 mM MgCl2, 150 mM imidazole, 0.01% Tween-20]. Fractions were pooled and dialyzed [25 mM tris (pH 7.5), 150 mM NaCl, 5% glycerol, 2 mM MgCl2]. The protein was further purified by tandem ion exchange chromatography by using an anion-exchange column connected to a cation exchange column. The complex was then eluted from the cation-exchange column [25 mM tris (pH 7.5), 1 M NaCl, 5% glycerol, 2 mM MgCl2]. Subsequently, the peak fractions were pooled and dialyzed into storage buffer [25 mM tris (pH 7.5), 150 mM NaCl, 5% glycerol, 2 mM MgCl2]. Purity was confirmed by gel electrophoresis and mass spectrometry.

Increasing concentrations of the Scc2-Scc4 complex ranging from 100 to 800 nM were incubated for 45 min with 50 ng of pUC19 at 30C in 25 mM tris-HCl (pH 7.0), 50 mM NaCl, 8% glycerol, bovine serum albumin (BSA; 0.1 mg/ml), and 0.5 mM dithiothreitol (DTT) in a final volume of 15 l. The reactions were resolved by electrophoresis for 1 hour at 80 V on 0.8% (w/v) tris-acetate-EDTA (TAE) agarose gels at 4C. DNA was detected on a fluorescent image analyzer (FLA-5000, Fujifilm) after SYBR Green I (Invitrogen, Thermo Fisher Scientific) gel staining. Condensin assays were carried out as previously described (20).

For cross-linking of cohesin complex, protein samples were incubated with BS3 at a 1:3000 molar ratio in buffer XL [25 mM Hepes, 125 mM NaCl, 5% glycerol, 1 mM DTT (pH 8)] for 2 hours on ice before quenching with 10 mM tris-HCl (pH 8) for 30 min on ice.

Negative-stain grids were prepared as follows: 3.5 l of suspended sample (final concentration of 0.02 mg/ml in buffer XL) was deposited on glow-discharged grids coated with a continuous carbon film. The sample was left on the grid for 1 min before blotting the excess liquid. A 3.5-l drop of 2% uranyl acetate solution was added for 1 min, the stain was blotted away, and the grids were left to dry.

A set of 250 micrographs was collected on a Philips CM200 TWIN FEG electron microscope operated at 160 kV. Images were recorded on a Tietz 2k charge-coupled device camera at a nominal magnification of 38,000 and a final pixel size of 3.58 , contrast transfer function (CTF) parameters were estimated using Gctf (40). A total of ~9000 particles were automatically picked using Gautomatch software using class averages obtained from a manually picked subset of 1500 particles as references. The following two-dimensional classifications were performed with RELION v3.0 beta (41).

Cohesin loading assays were done as described in (14) using the pUC19 plasmid. Topologically bound DNA-cohesin complexes were immunoprecipitated using a MACS HA Isolation kit (Miltenyi Biotec). Following incubation with Pst I and/or protein digestion, the recovered DNA was analyzed by electrophoresis on a 0.8% (w/v) TAE agarose gel in 1 TAE and visualized as described above.

For the ATPase assays, 30 nM cohesin was incubated at 29C with 60 nM Scc2/4 and 0.2 nM -DNA (New England Biolabs) in ATPase buffer [35 mM tris-HCl (pH 7.0), 20 mM NaCl, 0.5 mM MgCl2, 13.3% glycerol, 0.003% Tween-20, 1 mM tris(2-carboxyethyl)phosphine (TCEP), BSA (0.2 mg/ml)]. The reaction was started by adding 400 M ATP spiked with [-32P]ATP. One microliter of samples was taken after 1, 15, 30, and 60 min. The reaction was immediately stopped by adding 1 l of 50 mM EDTA before spotting the samples on polyethyleneimine cellulose F sheets. The free phosphate was separated from ATP using thin-layer chromatography with 0.5 M LiCl, 1 M formic acid as the mobile phase. The spots were detected on a phosphor imager and analyzed using ImageJ. Data points were corrected for spontaneous ATP hydrolysis. Each reaction was performed in triplicate. Data were fitted to Michaelis-Menten kinetics.

DNA curtain experiments were performed as described previously (42). Briefly, flow cells were produced by deposition of chromium features onto fused silica microscope slides by e-beam lithography. Flow cells were connected to a microfluidics system based on a syringe pump (Landgraf GmbH) and two injection valves (Idex) and illuminated by 488- or 561-nm lasers (Coherent) in a prism-type total internal reflection fluorescence (TIRF) configuration on an inverted microscope (Nikon Ti2e). Imaging was performed using an electron multiplying charge-coupled device (EMCCD) camera (Andor iXon life) with illumination times of 100 ms. -DNA (NEB) was end-modified by hybridizing biotinylated or digoxigeninated oligos complementary to the cos site and purified by size exclusion chromatography. Modified -DNA was anchored to the surface of a lipid bilayer in flow cells by biotin-streptavidin-biotin interactions, stretched by flow across chromium barriers, and anchored to downstream chromium pedestals by the digoxigenin-binding protein DIG10.3 (43). Experiments were performed in buffer M [40 mM tris-HCl (pH 7.8), 1 mM MgCl2, 1 mM DTT, BSA (1 mg/ml), 0.16 nM YOYO-1]. Cohesin complexes were labeled by incubating them at a concentration of 3 nM in a small volume of buffer M supplemented with 50 mM NaCl with 3 molar excess Qdots (SiteClick 705 kit, Invitrogen) fused to anti-HA antibodies (3F10, Roche) for 30 min at 4C. The mixture was then supplemented with 8 nM Scc2/Scc4, 100 m biotin, and 0.5 mM nucleotide (ATP, ADP, or ATPS), if required, before injection. For diffusion measurements, the flow cell was flushed after the completion of loading with buffer M supplemented with KCl at the indicated concentrations and the flow was stopped. Illuminations were performed either continuously (diffusion and lifetime measurements) or with lower frame rates (intermolecular bridging videos). To minimize photodamage, 488-nm pulses to illuminate the DNA, if required, were only used at every 10th illumination.

Videos were recorded in NIS Elements (Nikon) and analyzed using custom-written software in Igor Pro (WaveMetrics). Lifetime measurements and initial binding distributions of cohesin complexes on DNA were generated by manually analyzing kymograms. Survival curves were generated by a Kaplan-Meier estimator, bootstrapped, and fitted to a double-exponential model.

For the determination of diffusion coefficients, labeled cohesin complexes were tracked using custom-written software, and the diffusion coefficients were extracted using a maximum-likelihood estimator (44), as described previously (15).

Optical tweezers experiments were carried out on C-trap and Q-trap systems integrating optical tweezers, confocal fluorescence microscopy, and microfluidics and recorded using BlueLake software (LUMICKS). The laminar flow cell was passivated using 0.50% pluronic and BSA (2 mg/ml). Biotin-labeled double-stranded -DNA molecules were tethered between two streptavidin-coated polyesterene beads (4.42 m in diameter, Spherotech). Depending on the experiment, one or two individual double-stranded -DNA molecules were attached between two beads. The beads were previously passivated with BSA (1 mg/ml). After DNA capture, beads were incubated inside the protein channel either in a relaxed (~3 m apart) or extended position (force clamp at 5 pN, ~14 m apart) for 30 s and then returned to the buffer channel for FE, force clamp, and fluorescence analysis. Cohesin and Scc2-Scc4 complex were used at 1 nM and 2.5 nM concentrations, respectively. Beads and DNA catching and protein loading were performed in a buffer containing 50 mM tris-HCl (pH 7.5), 50 mM NaCl, 2.5 mM MgCl2, BSA (0.5 mg/ml), 40 M biotin, and 1 mM DTT. When indicated, ADP, ATPS, and ATP were added to both protein and buffer channels at a final concentration of 1 mM. Salt concentration was modified from 50 mM to 125, 300, or 500 mM NaCl in the buffer channel as specified in the text and figures. FE curves were performed at a speed of 1 m/s. Compaction experiments were carried out at a constant force of 1 pN. For friction experiments, beads were moved 6 m, back and forth, at a speed of 0.2 m/s. SYTOX Orange (Invitrogen, Thermo Fisher Scientific) was used at a final concentration of 50 mM for DNA imaging, using a 532-nm wavelength laser. Force data were processed using Igor Pro 7 software (WaveMetrics), and images were processed using Adobe Photoshop CC.

For Western blot, 2 g of purified complexes was run on NuPAGE 4 to 12% bis-tris gels (Thermo Fisher Scientific), transferred to Immobilon-P membranes (Millipore), and probed with anti-Strep (ab180957, Abcam, 1:5000) and anti-HA (3F10, Roche, 1:5000) antibodies in 5% milkphosphate-buffered saline (PBS)/0.01% Tween overnight at 4C. Membranes were then washed and incubated with horseradish peroxidase anti-rabbit (Santa Cruz Biotechnology, 1:40,000) and anti-rat (Jackson ImmunoResearch, 1:10,000) secondary antibodies, respectively, for 1 hour at room temperature. Immunoblots were developed using the Luminata Forte detection reagent (Millipore) and Hyperfilms ECL (GE Healthcare).

Samples were processed by in-Stage Tip digestion (PreOmics GmbH, Planegg/Martinsried) following the manufacturers recommendation. Protein digests were solubilized in 30 l of reconstitution buffer and transferred to autosampler vials for liquid chromatographymass spectrometry analysis. Peptides were separated using an Ultimate 3000 RSLC nanoliquid chromatography system (Thermo Fisher Scientific) coupled to an LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific) via an EASY-Spray source. Sample volumes were loaded onto a trap column (Acclaim PepMap 100 C18, 100 m 2 cm) at 8 l/min in 2% acetonitrile and 0.1% trifluoroacetic acid. Peptides were eluted online to an analytical column (EASY-Spray PepMap C18, 75 m 50 cm). Peptides were separated using a ramped 120-min gradient from 1 to 42% buffer B [buffer A: 5% dimethyl sulfoxide (DMSO), 0.1% formic acid; buffer B: 75% acetonitrile, 0.1% formic acid, 5% DMSO]. Eluted peptides were analyzed operating in positive polarity using a data-dependent acquisition mode. Ions for fragmentation were determined from an initial MS1 survey scan at 30,000 resolution [at mass/charge ratio (m/z) of 200] in the Orbitrap followed by CID (collision-induced dissociation) of the top 10 most abundant ions in the Ion Trap. MS1 and MS2 scan AGC targets were set to 1 106 and 1 105 for a maximum injection time of 50 and 110 ms, respectively. A survey scan m/z range of 350 to 1500 m/z was used, with CID parameters of isolation width 1.0 m/z, normalized collision energy of 35%, activation Q of 0.25, and activation time of 10 ms.

Data were processed using the MaxQuant software platform (v1.6.2.3) with database searches carried out by the in-built Andromeda search engine against the UniProt S. cerevisiae database (6729 entries, v.20180305). A reverse decoy database was created, and results were displayed at a 1% false discovery rate for peptide spectrum matches and protein identification. Search parameters included the following: trypsin, two missed cleavages, fixed modification of cysteine carbamidomethylation and variable modifications of methionine oxidation, asparagine deamidation, and protein N-terminal acetylation. Label-free quantification (LFQ) was enabled with an LFQ minimum ratio count of 2. Match between runs function was used with match and alignment time limits of 0.7 and 20 min, respectively. Protein and peptide identification and relative quantification outputs from MaxQuant were further processed in Microsoft Excel, with hits to the reverse database, potential contaminants (peptide list only), and only identified by site fields removed.

Acknowledgments: We thank J. C. Danes and J. Andrecka (LUMICKS) for technical help. We thank our laboratory members for discussion and critical reading of the manuscript. We thank D. DAmours, C. Haering, and J. Peters for sharing plasmids for the expression of yeast condensin and human cohesin. Funding: The work in the L.A. laboratory was supported by Wellcome Trust Senior Investigator award to L.A. (100955, Functional dissection of mitotic chromatin) and the London Institute of Medical Research (LMS), which receives its core funding (intramural program) from the UK Medical Research Council. J.S. acknowledges support by the Center of Nanoscience (CeNS) of Ludwig-Maximilians-Universitt as well as funding from the Deutsche Forschungsgemeinschaft (DFG) under grant STI673-2-1 and from the European Research Council under ERC grant agreement 758124. The Single Molecule Imaging Group is funded by a core grant of the MRCLondon Institute of Medical Sciences (UKRI MC-A658-5TY10), a Wellcome Trust Collaborative Grant (P67153), and a BBSRC CASE-studentship (to M.D.N.). Author contributions: P.G.-E. expressed and purified yeast cohesin and Scc2-Scc4 proteins and performed biochemical assays. J.D. expressed and purified yeast condensin. I.A. expressed and purified human cohesin. P.G.-E., M.D.N., and A.L. collected optical tweezers datasets. P.G.-E., M.D.N., and J.S. processed optical tweezers data. J.H. and L.T. performed ATPase assays. R.A. prepared electron microscopy grids and collected and processed electron microscopy images. H.K. and A.M. performed mass spectrometry analysis. J.H. and J.S. performed, collected, and analyzed DNA curtain datasets. P.G.-E. and L.A. conceived the project. L.A. wrote the manuscript. L.A., D.S.R., and J.S revised the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors. The plasmid for the expression of human cohesin was a gift by the laboratory of J. M. Peters. Requests should be submitted to IMP Vienna.

Follow this link:

A conserved ATP- and Scc2/4-dependent activity for cohesin in tethering DNA molecules - Science Advances

Black Friday Is Absolutely Massive. Here Are a Bunch of Deals We Couldn’t Call Out Individually – Gear Patrol

Want only the best Black Friday discounts? Sign up for the Gear Patrol Deals newsletter to get our editors favorite deals delivered straight to your inbox.

The Folk Ladder 32-inch Shelving leaning bookcase from Design Within Reach is $120 off.

Office Depot has the 11.6-inch HP Chromebook with 4GB of memory for $99 ($100 off).

Lalo is offering up The Daily Stroller for $390 ($125 off).

Normally priced at $120, Blue Bottles Three-Month Sampler Subscription is only $79 and includes free shipping.

Huckberry is offering a four-set of Whiskey Peaks American Mountains glasses for 25 percent off.

Bear Mattresses are 25 percent off at Huckberry.

Receive 20 percent off Stewart plaid throws from Faribault.

Get $40 off your first three weeks (with code BF40), $50 off your first four weeks (with code BF50) or $60 off your first five weeks (with code BF60) from Freshly.

Normally $749, the Bugaboo Cameleon 3 Plus Stroller is 25 percent off ($562).

Get Pranas Dameon Jacket for $139 (originally $199), as well as 30 percent off select styles.

Receive 30 percent off from Lifeproof on all items.

Huffys three-speed Comfort Commuter Bike is $60 off on Amazon.

Get 23andMes Health + Ancestry DNA Test for half-off ($99).

The OtterBox Venture 25 Cooler is only $161 (originally $230).

On Amazon, you can save 20 percent on select Soylent meal replacement shakes and protein bars.

Select Jack Links Beef Jerkey is 25 percent off on Amazon.

Get one dozen of Callaways CHrome Soft X Golf Balls for $35 (originally $45).

On Amazon, you can get the Segway Ninebot Max Folding Electric Scooter for $650 (savings of $149).

Janjis 5-inch AFO Middle Shorts are $51 (originally $60).

Cotopaxi is offering a tiered deal. Spend $100, get a free Mariveles Bundle. Spend $200, get a free Takark Bundle. Spend $500, get a free Sueo Sleeping Bag.

Get a Swell Onyx Roamer for 25 percent off.

At Isle Surf & SUP, save up to $125 on all surfboards and paddleboards and receive free shipping on select boards.

The United By Blue Summit Convertible Tote Pack is only $40 (originally $88).

Save $22 on Rhones Trek Merino Wool Henley.

The Toms Waterproof Black Waxy Suede Skully Boots are already discounted 25 percent, but you can get them for an extra 30 percent off with the code THANKFUL for a final price of $74.

Get $110 off Indochinos Durham Windowpane Gray Orange Suit.

Get up to 40 percent off (for first time subscribers) on all Adobe Creative Cloud apps.

Continue reading here:

Black Friday Is Absolutely Massive. Here Are a Bunch of Deals We Couldn't Call Out Individually - Gear Patrol

Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Co | IJN – Dove Medical Press

Fatima Aouidat,1 Sarah Boumati,2 Memona Khan,1 Frederik Tielens,3 Bich-Thuy Doan,2 Jolanda Spadavecchia1

1CNRS, UMR 7244, CSPBAT, Laboratory of Chemistry, Structures and Properties of Biomaterials And Therapeutic Agents University Paris 13, Sorbonne Paris Cit, Bobigny, France; 2UTCBS Chimie ParisTech University Paris Descartes - CNRS UMR 8258 INSERM U1022 Equipe Synthesis, Electrochemistry, Imaging and Analytical Systems for Diagnostics SEISAD, Paris, France; 3General Chemistry (ALGC), Vrije University of Brussel (Free University Brussels-VUB), Brussel, Belgium

Correspondence: Jolanda Spadavecchia Email jolanda.spadavecchia@univ-paris13.fr

Introduction: The development of biopolymers for the synthesis of Gd(III) nanoparticles, as therapeutics, could play a key role in nanomedicine. Biocompatible polymers are not only used for complex monovalent biomolecules, but also for the realization of multivalent active targeting materials as diagnostic and/or therapeutic hybrid nanoparticles. In this article, it was reported for the first time, a novel synthesis of Gd(III)biopolymerAu(III) complex, acting as a key ingredient of core-shell gold nanoparticles (Gd(@AuNPs).Material and methods: The physical and chemical evaluation was carried out by spectroscopic analytical techniques (Raman spectroscopy, UV-visible and TEM). The theoretical characterization by DFT (density functional theory) analysis was carried out under specific conditions to investigate the interaction between the Au and the Gd precursors, during the first nucleation step. Magnetic features with relaxivity measurements at 7T were also performed as well as cytotoxicity studies on hepatocyte cell lines for biocompatibility studies. The in vivo detailed dynamic biodistribution studies in mice to characterize the potential applications for biology as MRI contrast agents were then achieved.Results: Physicalchemical evaluation confirms the successful design and reaction supposed. Viabilities of TIB-75 (hepatocytes) cells were evaluated using Alamar blue cytotoxic tests with increasing concentrations of nanoparticles. In vivo biodistribution studies were then accomplished to assess the kinetic behavior of the nanoparticles in mice and characterize their stealthiness property after intravenous injection.Conclusion: We demonstrated that Gd@AuNPs have some advantages to display hepatocytes in the liver. Particularly, these nanoconjugates give a good cellular uptake of several quantities of Gd@NPs into cells, while preserving a T1 contrast inside cells that provide a robust in vivo detection using T1-weighted MR images. These results will strengthen the role of gadolinium as complex to gold in order to tune Gd(@AuNPs) as an innovative diagnostic agent in the field of nanomedicine.

Keywords: Gd-gold complex, theoretical study, MRI, relaxivity, biodistribution

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more:
Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Co | IJN - Dove Medical Press

How Home-Baked Bread Is Defying the Industrial Food System – YES! Magazine

As more home bakers rediscover how to capture wild yeast and turn it into nourishing loaves of bread, they are part of a growing kitchen movement standing up to the industrial food system.

Step 1: Capture wild yeast and make your own sourdough starter

Sourdough bread begins with the starter, made by capturing wild yeast from the environment and using it to ferment flour and water. Because yeast cultures vary depending on where you are, every sourdough starter tastes a little different. Heres how to make your own sourdough starter using an ancient grain.

Youll need:

Day 1: Mix 60g of flour with 60g of water, and let it sit for 24 hours at room temperature. (Do not sterilize your jar. Your starter uses naturally occurring and varied yeasts and lactobacilli bacteria from your environment.)

Day 2-5: Repeat the flour-water feeding. You should notice bubbles around day 2 or 3 (excitingyour starter is alive!). Once this happens, store your starter in the refrigerator to slow fermentation.

Day 6: At this point you should have an active starter. Give it a name! Throw out half of your starter and give it a hearty meal of 100g flour and 100g water.

To keep your starter alive, youll need to feed it equal parts water and flour every third day or so. I usually recommend 60g of water and 60g flour. If youre not planning to bake bread at the feeding time, throw out half the starter before feeding to keep your starter at a manageable size. It can take two to three bread-baking cycles before your starter is strong and yields predictable results. Professional bakeries have had their starters for generations.

Flour:

I chose einkorn wheat for this recipe. Einkorn was domesticated around 9000 B.C. Little about the grain has changed because it nearly became extinct and was never hybridized for industrial markets. Einkorn is noted for higher protein and nutrient content as well as gluten that is more digestible than that in industrial wheat. Emmer and spelt are also ancient grains that work for bread baking. You can experiment with different types and ratios of flour as long as the total added flour equals 500g. For example, if youre looking for a denser bread try a higher ratio of whole wheat flour.

Tools:

You might want to consider adding a couple of tools to your toolbox. Only the scale is absolutely necessary, but all will make bread-baking considerably easier.

Time:

2.5 hours plus a 12-hour cold bulk fermentation.

Ingredients:

Instructions:

1. Add the starter, water, and flour in a bowl. Mix well so that no dry flour remains. The mixture will be quite stickydo not worry. Let sit for 1020 minutes.

2. Add the salt and water mixture to the bread dough. Incorporate, mixing only as much as necessary. Let sit 1020 minutes.

3. Folding: In the bowl, grab the bottom of the north side of the dough. Stretch until just before it rips and then fold the dough towards you three-quarters of the way. Take the south side of the dough, stretch, and fold all the way over. Repeat this process with the east and west sides. Let the bread rest for 20 minutes. Then repeat this folding and resting step three more times.

4. Shaping: Lightly flour your work surface. Take the dough out of the bowl, and shape it so that its rectangular, arranging it so that the short side faces you. Take the south side of the dough, stretch it, and fold it up three-quarters of the way. Take the east side of the bread, stretch it, and fold it up and to the left. Repeat this with the west side. Then take the north flap and fold it all the way over the bread. Roll the dough so that the folding seams are underneath, touching your counter.

Use your hands to push the dough away from your body and then tuck it back toward you, creating surface tension along the outside of the dough. Rotate the dough with each push and tuck and continue this motion until the boule is a uniform shape with strong surface tension. This is not kneading, but shaping. Most sourdough, including this one, is actually a no-knead bread. We want the natural yeast to do as much of the work as possible.

5. Place your bread seam-side up in a lightly floured banneton. Cover with a tea towel and place it in the refrigerator for 12 hours.

6. Next day, preheat your oven (with the Dutch oven in it) to 500 degrees. Take out the Dutch oven, and gently roll your bread into it directly from the refrigerator. Sprinkle some flour on the top and score the dough by slashing the top. Put the lid on the Dutch oven and bake the loaf for 25 minutes. Then take the lid off, and bake for another 1520 minutes.

7. Remove the bread from the Dutch oven, and allow it to cool for about 10 minutes before slicing, sharing, and enjoying!

Originally posted here:

How Home-Baked Bread Is Defying the Industrial Food System - YES! Magazine

Study Reveals Hepatitis A Originated in Insects – Advanced Science News

Share

Share

Email

Hepatitis viruses are major threats to human health, resulting in the death of approximately 1.34 million people in 2015chronic infection from the viruses can severely damage the liver, leading to cirrhosis and hepatocellular cancer.

Despite sharing some common characteristics, such as a tropism for liver cells, human hepatitis viruses are extremely diverse and belong to different families. In recent years, the availability of high-throughput technologies has revealed that relatives of human hepatitis viruses can be found in a wide variety of animals, such as monkeys, woodchucks, rabbits, fish, and camels. By comparing infection patterns among viruses in human and animal hosts, scientists hope to gain a clearer understanding of the evolution and viral properties that led to human infection.

Now, researchers from the University of Arkansas for Medical Sciences and Molecular Microbiology and Genomics Consultants in Zotzenheim, Germany have reported a similarity between hepatitis A virus and the Triatoma virus that infects blood-sucking kissing bugs.

According to the studys lead author, Dr. Trudy Wassenaar, the codon use of hepatitis A virus (its preference for codons used to produce proteins from genes) is highly sub-optimal for propagation in its human host.

One would expect hepatitis A to have similarities to other hepatitis viruses, such as hepatitis C and E, as they all have similar genetic materials. Navely one could therefore think they would share genetic characteristics, but that is not the case, their genes are completely different, says Wassenaar. Nevertheless, the comparison of hepatitis C and E assisted in building a hypothesis and asking the right questions.

Mainly, why are hepatitis A infections self-limiting, while hepatitis C and E often cause chronic infections, and why does hepatitis A not propagate as quickly as the other two? The rules of evolution would not easily allow a virus to end up in such a bad situation [referring to its limited propagation], she says. We considered the possibility that there once existed an alternative host in which the hepatitis A virus had propagated and for which its codon use had been more optimized.

Two theories currently exist that try to explain this strange, sub-optimal performance. One proposes that hepatitis A uses uncommon codons to compete with the translational machinery of the host cell, while the other proffers that slower production of one particular protein is beneficial for its proper folding.

An evolutionary drive cant result in slower growth of a virus from an existing situation that allowed faster growth, says Wassenaar. That is simply impossible, so we dismissed [the first] theory. If [proper folding] had been the driving force to produce the observed codon use, one would expect the sequences coding for that [specific] protein to [be the only ones to] use uncommon codons, but that was not what we observed. Therefore, an alternative theory was needed.

The team therefore started looking for viruses that shared the same codons as hepatitis A virus, and surprisingly they found that some insect viruses were adequate matches.

To the best of our knowledge, this is the first example of a mammalian virus originating from an insect virus, but it most likely will not be the last. Further, it shows that a virus can maintain itself in a host even when it is not optimally equipped for that host. It illustrates just how versatile viruses can be, she adds.

To compare the genetic materials of the viruses, the team used specialized software that quickly calculates the frequency of each codon that a virus uses and compared the preference for codons of hepatitis A virus to the codons that human cells prefer.

Others had done this before us, but they had always corrected for particular differences and we deliberately omitted those corrections, says Wassenaar. That resulted in such an incredible difference: every single codon that human cells hate was preferred by the hepatitis A virus, and vice versa.

Then the team stumbled upon an insect virus that did exactly the same. That we found this was a bit of serendipity, as I was actually searching for something else. It was my lucky day! Suddenly all pieces of the puzzle matched. We then had to perform further analyses to convince ourselves, as it was a bit of a wild idea that an insect virus can actually propagate in mammals. But now we are convinced this is what happened, and we have started to look for other examples.

This study provides valuable insight into the evolution of human hepatitis viruses, challenging the idea that they all evolved from mammalian viruses.

See the original post:

Study Reveals Hepatitis A Originated in Insects - Advanced Science News

New Study Reveals US Airlines With the Healthiest Food Options – TravelPulse

Alaska Airlines offers the healthiest food choices among the 10 major U.S. carriers and tied with Air Canada for the best when folding in all major North American airlines, according to a study conducted by the Hunter College NYC Food Policy Center and DietDetective.com.

The Airline Food Study ranked the airlines on the nutrients and calorie levels of meals, snack boxes, and individual snacks.

Trending Now

Airlines were also scored on several other categories ranging from sodium levels in food, water quality, the availability of meals on flights that are under three hours long, level of transparency in terms of displaying nutritional information, and posting their menus and ingredients online.

Alaska Airlines scored a 4.0 on a five-point scale and was the highest-rated U.S. carrier in the study for the second straight year. Lead author Charles Platkin wrote he was pleased with many of the options Alaska offers, including Mediterranean Tapas snack box and its Fresh Start Protein Platter breakfast.

Rounding out the top five American airlines in the study were Delta and JetBlue, tied with a 2.9 score, and United and American at 2.7.

Hawaiian Airlines scored the lowest rating among carriers with full food offerings, and Southwest came in last with a score of 1.7 based mostly on the fact that the budget carrier offers only individual snacks.

"If the airline really does have a heart (as it does on its logo), it would care about the food thats being served. Southwest needs to add some healthy snacks," the authors wrote.

Visit link:

New Study Reveals US Airlines With the Healthiest Food Options - TravelPulse

Global Testosterone Replacement Therapy Market Capacity and Revenue Analysis Till AbbVie,Endo International,Eli lilly – Tech News Today

Global Testosterone Replacement Therapy Market 2019 report provides by Market Research Store is the representation of the testosterone replacement therapy Market area through research, development, and analysis of information from multiple sources. The Global testosterone replacement therapy report bifurcates the testosterone replacement therapy Market based on various parameters, including the nature of products and services, technology development and end-user applications for a better understanding of analytical data.

In the Testosterone Replacement Therapy Market 2019 research report professionals describe the different facets of the industry with a specific goal after assessing the key factors that could manipulate the development of the testosterone replacement therapy Industry sector. This article focuses on testosterone replacement therapy quantity and value at a global level, local level, and company level. From a global prospect, this report illustrates the overall testosterone replacement therapy market size by analyzing historical data and future forecasts. The Competitive landscape mapping the trends and outlook of the report which highlights a clear insight about the market share analysis of major industry players including AbbVie,Endo International,Eli lilly,Pfizer,Actavis (Allergan),Bayer,Novartis,Teva,Mylan,Upsher-Smith,Ferring Pharmaceuticals,Kyowa Kirin,Acerus Pharmaceuticals.

Get Sample For Technological Breakthroughs (Use official eMail ID to Get Higher Priority) at:https://market.us/report/testosterone-replacement-therapy-market/request-sample

Competitive Analysis

One of the most important sections of this report is competitive analysis and this why the team of experts in testosterone replacement therapy has left no stone unturned while investigating the global testosterone replacement therapy market. The precise section provides detail information about the overview of the company, product overview, and key developments associated with the precise company.

The most fundamental feature of this report is the inclusion of the SWOT analysis of key companies. SWOT analysis is helpful in giving information about threats and opportunities and weaknesses and strengths, which are faced by companies operating in the global Testosterone Replacement Therapy market.

To Get Instant Access, Purchase Report Here:https://market.us/purchase-report/?report_id=18112

Top growing factors by Key Companies like:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Current Market Status, Trends, Types:

GelsInjectionsPatches

Review of Market Growth, Future Prospects, andApplications:

HospitalsClinics

The Regional Segmentation Covers:

North America Region (U.S., Canada, Mexico)

Europe Region (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific Region (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America Region (Brazil, Argentina, Columbia, Rest of South America)

The Middle East & Africa Region (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Place An Inquiry Before Investment (Use Corporate Details Only):https://market.us/report/testosterone-replacement-therapy-market/#inquiry

Key Reasons to Purchase:

To achieve insightful analyses of the market and have a thorough understanding of the global Testosterone Replacement Therapy market and its commercial landscape.

Assess the Testosterone Replacement Therapy production processes, major issues, and solutions to mitigate the development risk.

To recognize the most affecting driving and constraining forces in the Testosterone Replacement Therapy market and its impact on the global market.

Discover about the market strategies that are being adopted by leading respective Industries.

To understand the outlook and prospects for the Testosterone Replacement Therapy

Browse More Insight Of This Premium Research Report Enabled with Respective Tables and Figures@https://market.us/report/testosterone-replacement-therapy-market/

People Also Interested In This Research

Global Climbing Helmets Market

Global Hair Serum Market Research Report 2019

Original post:
Global Testosterone Replacement Therapy Market Capacity and Revenue Analysis Till AbbVie,Endo International,Eli lilly - Tech News Today

Testosterone Replacement Therapy Market Analysis, Growth Rate, Overview, Market Segmentation and Forecast By 2024 – The Charterian

Testosterone Replacement Therapy Market 2019-2024 report also carries in-depth case studies on the various countries which are actively involved in the Testosterone Replacement Therapy production. An analysis of the technical barriers, other issues, cost effectiveness affecting the Testosterone Replacement Therapy Market. Determining the opportunities, future of the Testosterone Replacement Therapy and its restraints becomes a lot easier with this report.Testosterone Replacement Therapy Market report contains a focused socio-economic, political, and environmental analysis of the factors affecting the Testosterone Replacement Therapy industry. The report contains an analysis of the technologies involved in production, application and much more.

AccessGlobal Testosterone Replacement Therapy Market Research ReportDetails at: athttps://www.pioneerreports.com/report/301292

About Testosterone Replacement Therapy Industry

Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new GIR (Global Info Research) study.This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The overviews, SWOT analysis and strategies of each vendor in the Testosterone Replacement Therapy market provide understanding about the market forces and how those can be exploited to create future opportunities.

Key Players in this Testosterone Replacement Therapy market are:

Request for Sample Copy of this Testosterone Replacement Therapy Market Report athttps://www.pioneerreports.com/request-sample/301292

Production Analysis:SWOT analysis of major key players ofTestosterone Replacement Therapy industry based on a Strengths, Weaknesses, companys internal & external environments. , Opportunities and Threats. . It also includesProduction, Revenue, and average product price and market shares of key players. Those data are further drilled down with Manufacturing Base Distribution, Production Area and Product Type. Major points like Competitive Situation and Trends, Concentration Rate Mergers & Acquisitions, Expansion which are vital information to grow/establish a business is also provided.

Application of Testosterone Replacement Therapy Market are:

Product Segment Analysis of the Testosterone Replacement Therapy Market is:

Geographically this report covers all the major manufacturers from India, China, USA, UK, and Japan. The present, past and forecast overview of Testosterone Replacement Therapy market is represented in this report.

The report gives summary of the impact of the key drivers, restraints, and popular trends in the Testosterone Replacement Therapy market. These factors are studied on regional and the global front, for varying levels of depth of market research. Overall overview of the factors affecting various decisions in the global market is presented and examined by policies in the market, regulatory scenario of the market, with the help of details of key rules, regulations, plans, and policies in the market. The report presents detailed analytical account of the markets competitive landscape, with the help of detailedbusinessprofiles, project feasibility analysis, SWOT analysis, and several other details about the key companies operating in the Testosterone Replacement Therapy market. The report also presents an outline of the impact of recent developments on markets future growth forecast.

Geographically this report covers all the major manufacturers from India, China, USA, UK, and Japan. The present, past and forecast overview of Testosterone Replacement Therapy market is represented in this report.

The report gives summary of the impact of the key drivers, restraints, and popular trends in the Testosterone Replacement Therapy market. These factors are studied on regional and the global front, for varying levels of depth of market research. Overall overview of the factors affecting various decisions in the global market is presented and examined by policies in the market, regulatory scenario of the market, with the help of details of key rules, regulations, plans, and policies in the market. The report presents detailed analytical account of the markets competitive landscape, with the help of detailedbusinessprofiles, project feasibility analysis, SWOT analysis, and several other details about the key companies operating in the Testosterone Replacement Therapy market. The report also presents an outline of the impact of recent developments on markets future growth forecast.

Inquire for further detailed information of Testosterone Replacement Therapy Market Report at:https://www.pioneerreports.com/pre-order/301292

Testosterone Replacement Therapy Market Report Highlights:

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Testosterone Replacement Therapy market. The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

In this study, the years considered to estimate the market size of Testosterone Replacement Therapy Market are as follows:-

Single User Licence Price: USD 3480

No Of Pages in Testosterone Replacement Therapy Market Report: 120

Purchase of Testosterone Replacement Therapy Market Report at:https://www.pioneerreports.com/checkout/301292

Go here to read the rest:
Testosterone Replacement Therapy Market Analysis, Growth Rate, Overview, Market Segmentation and Forecast By 2024 - The Charterian

Testosterone Replacement Therapy Market 2019 Global Industry Insights, Innovations, Key Players Analysis, Growth Strategies and Forecast Analysis 2019…

This new research report that entirely centers Global Testosterone Replacement Therapy Market 2019 is an exhaustive analysis of driving forces, risks, challenges, threats, and business opportunities, involved in the Testosterone Replacement Therapy market. It offers conclusive specks of the market such as major leading players, market size over the forecast period of eight years, segmentation analysis, market share, current market trends, movements and major geographical regions involved. The report includes a comprehensive market study and competitors landscape with the addition of a SWOT study of the leading vendors.

This report analysis also studies the product and business strategy of some of the key vendors in the market. Considering the segmentation in the Testosterone Replacement Therapy market, key vendors in the market are highlighting mergers and collaborations and advancing their supply chains.

Get Sample PDF Brochure (including full TOC, Tables, and Figures) of Testosterone Replacement Therapy Market @ https://researchindustry.us/report/testosterone-replacement-therapy-market-ric/759945/request-sample

THANKSGIVINGWe are offering Upto 40% Discount on the full report purchase! For transactions only till 5th December 2019.

Testosterone Replacement Therapy Market Impressive Report Offerings:

Some of the Major Testosterone Replacement Therapy Market Players Are:

Acerus PharmaceuticalsFerring PharmaceuticalsKyowa KirinMylanUpsher-SmithActavis (Allergan)BayerNovartisTevaPfizerAbbVieEndo InternationalEli lillyAnd Others

The global Testosterone Replacement Therapy market report covers scope and product overview to describe the key terms and offers detailed information about market dynamics to the readers.

This is followed by the segmental analysis and regional outlook. The report also comprises of the facts and key values of the global Testosterone Replacement Therapy market in terms of sales and volume, revenue and growth rate.

One of the significant factors in the global Testosterone Replacement Therapy market report is competitive analysis. The report covers all the key factors such as product innovation, market strategies of the key players, market share, latest research and development, revenue generation, and market expert views.

For Best Discount on purchasing this report,(Price 2000 USD for a single-user license) Visit: https://www.researchindustry.us/checkout?report=759945&type=single

Testosterone Replacement Therapy market regional Analysis

The global Testosterone Replacement Therapy market is fragmented across the globe which not only includes the market of North America but covers the other regions such as Europe, the Asia Pacific, South America, and the Middle East.

North American countries, especially the U.S. and Canada represent noteworthy growth in this market. Similarly, Western European regions are also ahead in influencing the global markets.

Here are the questions we answer

Customize report and inquiry before the purchasing this report @ https://researchindustry.us/report/testosterone-replacement-therapy-market-ric/759945/request-customization

Get In Touch!

Navale ICON IT Park,

Office No. 407, 4th Floor, Mumbai Banglore Highway, Narhe, Pune

Maharashtra 411041

phone +91-844-601-6060

Email sales@researchindustry.us

Read the rest here:
Testosterone Replacement Therapy Market 2019 Global Industry Insights, Innovations, Key Players Analysis, Growth Strategies and Forecast Analysis 2019...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yunji, Plantronics, Lipocine, and Armstrong…

NEW YORK, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Yunji, Inc. (YJ), Plantronics, Inc. (PLT), Lipocine, Inc. (LPCN), and Armstrong Flooring, Inc (AFI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Yunji, Inc. (YJ)

Class Period: Securities purchased pursuant and/or traceable to the registration statement and prospectus (collectively, the Registration Statement) issued in connection with the Companys May 2019 initial public offering (IPO or the Offering).

Lead Plaintiff Deadline: January 13, 2020

On May 3, 2019, the Company held its IPO in which it sold 11,217,447 shares for $11.00 per share.

On August 22, 2019, the Company disclosed a supply chain restructuring that shifted part of its merchandise sales to its marketplace platform, resulting in a year-over-year decrease in total revenues for second quarter 2019.

On this news, the Companys share price fell $1.21, or nearly 11%, to close at $9.39 per share on August 22, 2019. Yunjis share price continued to decline by $3.34, or over 35%, over the next three consecutive trading sessions to close at $6.05 per share on August 27, 2019.

By the time this class action was filed, Yunjis shares were trading as low as $4.40 per share, a nearly 60% decline from the $11 per share IPO price.

The complaint, filed on November 12, 2019, alleges that the Registration Statement was false and misleading and omitted to state material adverse facts. Specifically, Defendants failed to disclose to investors: (1) that the Company was shifting certain of its sales to its marketplace platform; (2) that this supply chain restructuring was likely to disrupt Yunjis relationships with suppliers; (3) that this supply chain restructuring was likely to have an adverse impact on the Companys financial results; and (4) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Yunji class action go to: https://bespc.com/yj

Plantronics, Inc. (PLT)

Class Period: July 2, 2018 to November 5, 2019

Lead Plaintiff Deadline: January 13, 2020

On November 5, 2019, the Company disclosed a $65 million reduction in channel inventory by reducing sales to channel partners and decreased its fiscal 2020 guidance, expecting revenue between $1.72 billion and $1.81 billion and adjusted EBITDA between $282 million and $323 million. Plantronics also reported that its Executive Vice President of Global Sales was leaving the Company.

On this news, the Companys stock price fell $14.44 per share, or nearly 37%, to close at $25.00 per share on November 6, 2019.

The complaint, filed on November 13, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; (3) that the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Plantronics class action go to: https://bespc.com/plt

Lipocine, Inc. (LPCN)

Class Period: March 27, 23019 to November 8, 2019

Lead Plaintiff Deadline: January 14, 2020

Lipocines lead product candidate is TLANDO (LPCN 1021), an oral testosterone replacement therapy. The Company has previously submitted New Drug Applications (NDA) for TLANDO twice and, both times, received Complete Response Letters (CRL) from the U.S. Food and Drug Administration (FDA) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018.

Story continues

On March 27, 2019, Lipocine issued a press release announcing new topline results from a study evaluating TLANDOs effects on blood pressure (one issue cited by the FDA in a prior CRL rejecting TLANDOs NDA), as well as the Companys intention to refile the NDA for TLANDO in the second quarter of 2019.

On November 11, 2019, Lipocine issued a press release announcing receipt of a CRL from the FDA regarding its NDA for TLANDO. In the press release, Lipocine advised investors that the FDA had again rejected the NDA for TLANDOthis time because an efficacy trial had not met three of its secondary endpoints.

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

The Complaint, filed on November 14, 2019, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Companys business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the results from Lipocines clinical studies of TLANDO were insufficient to demonstrate the drugs efficacy; (ii) accordingly, Lipocines third NDA for TLANDO was highly likely to be found deficient by the FDA; and (iii) as a result, the Companys public statements were materially false and misleading at all relevant times.

For more information on the Lipocine class action go to: https://bespc.com/lpcn

Armstrong Flooring, Inc. (AFI)

Class Period: March 6, 2018 to November 4, 2019

Lead Plaintiff Deadline: January 14, 2020

On May 3, 2019, Armstrong Floorings Chief Executive Officer abruptly resigned.

On this news, the Companys stock price fell $1.75, nearly 12%, to close at $13.14 per share on May 3, 2019.

Then, on November 5, 2019, Armstrong Flooring reported $165.6 million net sales for third quarter 2019, a nearly 21% decline year-over-year, and a net loss of $31.4 million. The Company also cut its full year 2019 guidance for adjusted EBITDA to a range of $20 million to $25 million, from prior guidance range of $46 million to $54 million, citing larger distributor movements on inventory than anticipated.

On this news, the Companys stock price fell $2.90 per share, or nearly 44%, to close at $3.70 per share on November 5, 2019.

The complaint, filed on November 15, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; and (3) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Armstrong Flooring class action go to: https://bespc.com/afi

About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit http://www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Read more:
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yunji, Plantronics, Lipocine, and Armstrong...

Ticking all boxes of a healthy life – The New Indian Express

Express News Service

The first day of the year 1977 brought with it a son to a farmers family in Rajpura district of Rajasthans city of Sikar. The son would grow up not only to become a physician, a sportsperson and a politician but also a soldier.

Watching his father, Gulab Chand, and family work relentlessly, sometimes for 14-16 hours a day, to earn a decent living, made the young boy understand the value of hard work, something which he didnt forget ever.

My parents have been my mentors. I get inspired watching their passion for environment, animals and farming, says Major (Dr) Surendra Poonia who not only happens to be a Special Forces officer in the Indian Army but also an international athlete and the first Indian to have won medals in powerlifting and athletic events in four consecutive world championships. A part of sports and active nutrition brand, Fast&Ups 30-day #StepChallenge, the founder of Soldierathon talks to us about the importance of fitness. Excerpts:

How did you become a part of the 30-day #StepChallenge?

It was started to make people aware about the importance of active and healthy lifestyle. I wanted to do something which is easy to follow and everyone can participate in. With #StepChallenge, all you need to do is walk and record the number of steps you take every day.

The fact is that urban India is getting inactive due to hectic daily life and introduction of modern budgets. They are walking averagely less than 8,000 steps per day. As per latest research, these number of steps are not sufficient to lead a healthy life. Self-care and health is not a weekend thing. Self-care needs to be included in our daily routine and this challenge is a step in that direction.

By when do you think will India be a healthy and happy nation?

India is moving in the direction of a healthy nation. I believe being happy is a state of mind that will happen, when you are healthy! For me, happiness is when I see more people pushing themselves every day to clock more steps, the discipline with which a lot of people are participating every day. I feel proud of the community this challenge has been able to make and even more happy that I am a part of it. I cannot wait to have more active Indians be a part of this fit Bharat Army!

Having won medals globally for various sports, how do you see the nations progress in sports today?

We still have a long way to go. We need the right infrastructure to make our sportspersons shine at the world level. But the good thing is we are moving in the right direction to hone the talent of our nation.

A soldier, a politician, a sportsperson and a physician which role do you cherish the most and why?I truly believe I am and will always be a soldier first. The Indian Army has given me everything that has skilled me to do the rest to the best of my abilities. I will continue to serve my nation in whatever capacity, till my last breath.

Follow this link:
Ticking all boxes of a healthy life - The New Indian Express

Heres How Sabbatical Beauty Owner Takes Care of Her Own Skin and Health – phillymag.com

Sweat Diaries

Adeline Koh, founder and owner of Korean-inspired skincare company Sabbatical Beauty, runs on yoga, martial arts, and kombucha.

A week in the life of Adeline Koh, founder and owner of Sabbatical Beauty, Phillys Korean-inspired skincare company. / Photograph courtesy of Adeline Koh.

Welcome to Sweat Diaries, Be Well Phillys look at the time, energy, and money people invest in pursuit of a healthy lifestyle in Philly. For each Sweat Diary, we ask one area resident to spend a week tracking everything they eat, all the exercise they get, and the money they spend on both. Want to submit a Sweat Diary? Email lbrzyski@phillymag.com.

Who I am: Adeline Koh (@adelinekohphd, @sabbaticalbeauty), 40

Where I live: Graduate Hospital

What I do: I founded and run Sabbatical Beauty, a luxury, handcrafted Korean-beauty inspired skincare company. I formulate all my serums, cleansers, toners, and masks myself and we hand-make everything in our lab/studio in the Bok Building.

Before that, I was a tenured English professor at Stockton University, and Ive also held fellowships at the National University of Singapore, Duke University, and the University of Pennsylvania. I left academia for Sabbatical Beauty in 2017. It all started when I went on sabbatical and started to formulate my own Korean beauty products because I was unhappy with the existing formulations out there. Many mainstream Korean beauty products proclaim they have things like Ginseng in them, but the botanical active ingredient is usually low on the ingredient list. I started making my own products and my skin got so much better that my other professor friends wanted in on the action. I started an online shop and did well enough that I saw a way to focus on running my own company full-time.

What role healthy living plays in my life: It would surprise most people who I grew up with that Im as active as I am, given that 1.) I was the sickly kid who always sat out gym class because of asthma, and 2.) Im very uncoordinated and have a terrible sense of balance. I would say though that what I do have is a dogged ability to work hard, and a lack of embarrassment at how bad I look when Im doing something. I find that these two qualities have helped me move across different fields throughout my life from transitioning out of a tenured English professor position to becoming a small business owner to trying to learn martial arts when you get right and left mixed up a lot.

Health memberships (and what they cost):

In between writing content to promote on Sabbatical Beautys social platforms, Koh makes an Asian rice and tuna bowl for lunch. / Photograph by Adeline Koh.

7 a.m. Up slightly later today because my rescue pup Cooper had an upset stomach last night and I had to get up in the middle of the night to clean up his accident. Wake up and offer the poor pup a smaller breakfast today because hes under the weather.

7:30 a.m. I make myself a raspberry passion perfect energy Yogi tea and start working immediately. I set aside most of today to do a lot of web design, including creating a new blog post on my upcoming Crystal Queen skincare collection. Other things I have to work on today: updating my social media ads, creating and scheduling Facebook and Instagram content, and a whole lot of other things like renewing business insurance.

11:45 a.m. Still working and theres so much I have to do that Im barely making a dent yet. I drink a Brew Doctor Kombucha (I cant get enough of kombucha). I usually try to intermittent fast on most weekdays because it helps me to think more clearly, so my first meal is lunch, and kombucha gets me through the mornings. I also do a quick skin refresh with my micellar beauty water on a cotton pad, add some donkey cream and sunscreen (the single most important step to preventing further signs of aging).

1:30 p.m. Not really hungry but I know I need to eat. I make my own Asian rice bowl with good quality canned tuna, short grain white rice, sesame oil, green onions, and masago, plus some nori on the side. I follow that up with a few slices of pandan honeycomb cake made by Monmoney Prak from my skincare brunch party with Caphe Roasters last weekend.

2 p.m. My poor pup just started throwing up red chunks. Im worried and call the vet. I was supposed to check out Freehouse Fitness for a class with my friend Nicole Rossi, my Bok neighbor who creates the most gorgeous floral arrangements. But since Cooper is sick, I cancel my evening plans to take him to the vet.

6 p.m. Our vet at World of Animals is giving him an anti-nausea injection and some fluids, and says he should be okay. Thank goodness! My husband says, I came with an dog, I left with a camel because hes got a little bit of a hump on his back where the fluids were injected.

6:45 p.m. I stop by the grocery store to pick up canned chicken for Coops as he needs a bland diet for the next week. I also grab chili toppings for my husbands dinner tomorrow and some Greek yogurt for myself ($24.23).

7:20 p.m. I do an at-home martial arts workout since I missed my other planned one. Warm up with jumping jacks, mountain climbers, pushups, regular and jump squats. I do a bunch of drills (flutter kicks, regular kicks, my studio Martial Postures version of the Dirty Dozen), and do a bunch of hip stretches. It takes me about 40 minutes with some rest in between drills.

8:30 p.m. I make Tamago Kake Gohan with instant dashi, leftover katsobushi, and green onions with soy sauce. Topped with masago and nori. Tastes amazing, looksnot so much. I then have a few leftover pandan waffles from last weekend, plus another kombucha.

10 p.m. Time for my shower and skincare routine. I use an oil cleanser (my vacuum cleaner cleansing oil), my inflammation reducing Chang Es silver moon pearl serum, my cannabis sativa balm (no THC), and then do my Guasha facial massage routine to settle down before going to sleep.

Daily total: $24.23

As a thank-you for helping cover the counter, Koh is treated to complimentary lunch at Poi Dog Philly. / Photograph by Adeline Koh.

6 a.m. I wake up, but am too busy snuggling my dog child in bed to actually get up until 7 a.m.

8 a.m. I was scheduled to go to a women in food and hospitality meeting at Barbuzzo (my philosophy is that my skincare is basically my grandmas soup on my face) but Coops is being clingy and a little off, so I decide to work from home instead to keep an eye on him.

8:30 a.m. My manager calls in sick. Everyone is sick or getting sick. Really hoping Im not next! I drink a Yogi tangerine stress relief tea followed by a kombucha to try to keep the germs away. I get back to work on my insurmountable pile of to-dos.

11 a.m. I take Coops with me as I drop off some Sabbatical Beauty goodie bags to Kiki Aranita at Poi Dog Philly for a party that shes catering. Kiki also hooks me up with a free lunch because I helped her cover her counter last week for a few hours as her counter staff is in the hospital for a broken leg. I tell her that for her food, I will work for her whenever she needs me.

11:30 a.m. I said to myself that Id try to not eat fried chicken during this Sweat Diary but obviously I lied to myself. Poi Dogs mochi nori chicken with red cabbage and short grain rice is incredible. I eat half the plate lunch and two coconut butter mochis and feel instantly happier.

12 p.m. Its snowing out, although that wasnt in the forecast. I make chili using this recipe for my husbands dinner and shredded chicken breast for Coopers treats this week.

1 p.m. Back to computer work. I write copy, create graphics, and schedule a few social media posts. Coops is doing better, now bugging me for table scraps which I cant give him because he needs to stick to a bland diet. I boil some chicken and shred it to give to him as replacement treats.

3 p.m. I head over to Bok to prep for a skincare party Im throwing for some of the Philly Mag staff.

4:30 p.m. The staff arrives and I give Gin
a Tomaine a hug as weve been fans of each others work for a while now, despite never having met. We enjoy some wine as they try all the steps and mask. Once they leave, I clean up and head over to my martial arts class.

7 p.m. I arrive at Martial Posture. I started learning martial arts here a few months ago and am addicted because of how challenging it is, and because it melds so many different aspects of physicality: flexibility, movement, cardio fitness, strength, and precision. Its hard af but my instructors Vicente and Thomas are super sweet and always encouraging, making it easy to want to keep learning. In tonights adult class, I learn a new Judo technique called O-goshi, a major hip throw. I really suck at it but I get better the more I practice. Thats what I appreciate about it, working at the drills piece by piece means eventually I can execute the movement, just with enough patience and relentlessness.

8:30 p.m. I am home and starving. I eat my leftover mochi nori chicken with additional rice, top it with masago, one spam musubi, three little chocolate wafers and the rest of the coconut butter mochi. I am sad that the mochi is gone and make a mental note that I need more in my life. I have another kombucha.

10 p.m. I shower and realize I totally forgot to do my skincare routine this morning. Bad beauty boss. I do the same routine as last night, watch MSNBC as I play Angry Birds Match to wind down, and then go to bed.

Daily total: $0

To start off most weekday mornings, Koh rolls out her mat and flows at Amrita Yoga. / Photograph by Adeline Koh.

6 a.m. I wake up, pet Coops, feed him and take him out, and thank the stars that yoga is 5 minutes away. I think the universe listened when I said that I needed a yoga class I had no excuse not attending when Amrita Yoga opened up so close to me.

6:30 a.m. Yoga with Tracy Phoenix. I love this space so much. I usually come early to sit in heart bench for a while. Tracy is amazing as usual, super tuned in to the classs energy. She leads us through an energetic, challenging flow that heats us up and stretches us out for the day. I leave in a good mood.

7:45 a.m. I hit the grocery store to stock up on kombucha (theres a special going on!) and more chicken for Coops ($21.52). Coops is doing better, although his GI is definitely still stressed out (lets just say someone has been stinking up rooms a lot).

8:15 a.m. Back home for another work-from-home day. I vow to get my crystal skincare collection blog finally written today. I open and consume one of the new kombuchas I just bought.

12 p.m. Been making some headway on copy, finally. I eat my last spam musubi and make a rice bowl with plain rice and these *amazing* seitan red-braised meatballs that Ange from the amazing Malaysian restaurant Im obsessed with, Sate Kampar, made last weekend. I get full a few bites into the rice bowl and put it away for later.

4:45 p.m. I snack on a Greek yogurt, some toasted nori strips, and the last few slices of the pandan honeycomb cake (*sob*).

5:30 p.m. Im still behind in work, so I decide to skip my evening martial arts class and continue working.

6:30 p.m. I stress-eat a few chocolate covered cookies and almonds which makes me realize I need breakfast for dinner to satisfy my sweet tooth: I have rolled oats with protein powder and maple syrup topped with almond butter. I then make myself a berry orange tea with some hydrolyzed collagen.

9:30 p.m. I have another kombucha and decide to head to bed in half an hour. Exhausted.

Daily total: $21.52

Kohs evening skincare routine includes her hand-made oil cleanser, inflammation-reducing serum, THC-free cannabis sativa balm, and a Guasha facial massage. / Photograph by Adeline Koh.

7 a.m. Still exhausted despite sleeping in a bit. Feed Coops who is upset he cant have his regular treats yet. Hes doing a lot better, though.

8 a.m. I reschedule some appointments originally happening today for next week since I need to get my online work finally completed. Its another day in a creative hole. I also need to plan out updating my customer touch point journeys. Im overwhelmed with everything I have to do, but I usually am! I get started with some Yogi tea.

10 a.m. Im finally on a roll, hoping it keeps going! I have a great idea for Instagram engagement and just posted it.

11:30 a.m. Still on a roll. I have another kombucha. Did I mention I was working on a kombucha skincare line for spring 2020 as a collaboration with Inspired Brews? Its going to be awesome!

1 p.m. I get stuck with a photo editing issue, so I decide to take a break and make lunch. I make a quick dashi broth with kombu kelp and anchovy stock and make a pumpkin tofu miso soup.

3:45 p.m. I finally finish my behemoth project: the crystal collection blog post. Now for all the plugging and scheduling. Im exhausted, but the biggest thing is done for the week. Now for all the fires that have been waiting for me

4:45 p.m. I eat a few handfuls of dark chocolate covered almonds and a little dish of Annies cheddar bunnies.

6 p.m. I arrive at Martial Posture to join the teen class because my usual instructor Vicente isnt around. We do conditioning for most of the class, and then work on some kickboxing drills after. I have a really nice partner named Trione.

7 p.m. I stay for a second class because enough people come for an adult session and Thomas the instructor says its okay to stay if I want to work out more. I basically cant get enough of martial arts so Im like heck yes! We work a lot more on techniques in this class, ending with working a lot on the O-goshi throw I started learning on Tuesday.

8 p.m. Stop at Tsuki Sushi to pick up dinner for me and the husband. I get the three roll special ($47.80).

9 p.m. Craving some sweetness, so I eat three chocolate covered cookies and have a kombucha.

10:30 p.m. I shower, realize again I am a bad beauty boss because I forgot to do my morning routine. I end the evening with my go-to skincare regimen.

Daily total: $47.80

After a rigorous training session, Koh poses with Ish, the owner of Martial Posture. / Photograph courtesy of Adeline Koh.

6 a.m. Im up and the dog wants to snuggle so its hard to drag myself out to go to yoga.

6:30 a.m. Yoga with Tracy again. Im always amazed at what an amazing teacher Tracy is and what command she has of the physical body and how to explain how it works to people. This morning she basically has does do flows with every yoga lunge you can think of, and the final flow has vinyasa thrown in between each lunge. It is obvious and fitting then that I leave sweaty af. I think sweatier than after my two-hour martial arts sessions yesterday.

8 a.m. Check in at work on my laptop, then take a shower and do my morning routine. This morning its my vacuum cleaner cleansing oil, the brightening Carols sake and rice serum, and donkey cream followed with sunscreen.

11 a.m. Im at Bok meeting Jessica Weaver because Im starting to research traditional Chinese medicine more and developing TCM-influenced products like the Chang Es silver moon pearl serum. Jessica tries on all the SB (you can do that too if you make an appointment for a Skincare Party for One with us). We also plot putting together an Asian skincare event where folks come and wear masks while getting acupuncture at the same time for 2020.

1:30 p.m. I walk a few blocks from Bok to get to I Heart Cambodia. Their food is amazingly done with care and attention I dont often see outside of Southeast Asia. I get the Cambodia seafood rice soup and fried dough (really similar to the Chinese fried crullers I grew up eating with congee) ($13).

5 p.m. My staff left but Im still editing photos for Instagram and working on some content in the office.

6:15 p.m. I get to Martial Posture, super excited because I get to work with Ish, who is the owner. Im always amazed by how he executes postures without even really seeming to put effort into it. Today hes worki
ng with me on the spinning back kick, and some moves that will lead into some pretty intense spins. I do a starter version of what will one day turn into fake-out kicks with one leg and kicks with the other leg all while spinning around. We then end by practicing sets one through 10.

7:30 p.m. I pick up dinner from Rosys Taco Bar ($73.56). I get a tequila shot while waiting because why not.

9 p.m. For dessert tonight: a chocolate Pejoy (basically filled Pocky sticks) packet and two kombuchas.

Daily total: $86.56

Money spent: $180.11Workouts completed: SevenKombuchas consumed:10

Want to hear more from us? Join Be Well Philly at:FACEBOOK|INSTAGRAM|NEWSLETTER|TWITTER

Visit link:
Heres How Sabbatical Beauty Owner Takes Care of Her Own Skin and Health - phillymag.com

Periodic Fasting for a Healthy Lifestyle! Read on to know how its better than starving all day long!! – Morning Picker

There is an old saying: When the stomach is full, it is easy to talk of fasting, so far its literally true. You can find a numerous opinions about diets but will find a lesser talks about the pros and cons of intermittent fasting.

People said that man had changed a lot, the weakness of peoples health no longer allows us to fast. Then again a question arises, Was it true? To which the answer is that fasting blinds the body in order to open the eyes of your soul and works as the greatest physician within the body. Its a magical rest for the whole system and enlightens up with cheers and energy.

Starting an intermittent fasting protocol is one of the best healthy living choices that one can admire in its lifestyle. Losing weight is the number one reason why people start a fasting protocol as fasting allows you to restrict calorie intake without excessive counting.

The obesity contagious has generated a cottage industry of weight-loss strategies. Presently in fashionable is periodic fasting, which comprises wavering intervals of utmost calorie cutback with periods of normal eating. Partisan of a periodic fasting procedure petitioned that it helps take off pounds faster than traditional diets, as well as reduce inflammation and other heart disease risks.

Some commercial companies have initiated marketing bundled feast suggestions designed explicitly for periodic fasting. While this may make the process obvious for some people, these products lean to be expensivearound $300 for a weeks valuation of food.

Fasting promotes better overall health and longevity, still advances the anxiety to overeat on breaking it. Folks with diabetes or other metabolic disorders along with people taking medications that require food must avoid fasting.

Overall fasting is the first principle of medicine.

November 26, 2019 1:52 pm EST 1:52 pm EST

Continued here:
Periodic Fasting for a Healthy Lifestyle! Read on to know how its better than starving all day long!! - Morning Picker

‘The Bachelor’: Cassie Randolph Reveals Her Skincare, Diet, and Workout Routine – Showbiz Cheat Sheet

Ever since Cassie Randolph won Colton Underwoods season of The Bachelor, fans have been enamored of her beauty secrets.

As many Bachelor stars go on to do, Randolph now makes a habit of linking her outfits in Instagram photos and sharing skin tips (mostly via advertisements) in her stories. But shes never really been explicit about her entire beauty/health routine.

In a recent Instagram Q&A the reality star did on her stories, she shared some of her tips and tricks.

What skincare products do you use? How is your skin so clear! asked one fan.

Hate myself, because Ive been meaning to do a skincare video for so long now like Ive promised a million times. Its hard because its always changing as I try new products, she responded.

But Randolph shared a few staples that dont ever change: RetinA @ night, sunscreen everyday, vitamin C serum, AHA or BHA, moisturizer.

Another fan asked Randolph if she has permanent makeup on your lips because theyre always so red.

Ive always had really red lips, she responded, including a baby photo of herself with a strikingly red pout. But I know a couple people who have done the permanent lip liner & love it!

Randolph speaks a lot about how its important to her to maintain a healthy lifestyle. She admitted in her recent Q&A that her diets been inconsistent lately since shes been traveling so much, but that she tries to eat as clean as possible.

Do you stick to a certain diet/workout routine? asked another fan.

gonna be honest, with everything going on and all the traveling this past year, Ive been super inconsistent with diet/exercise. I try to eat as clean as possible and listen to my body, Randolph responded. I actually have a lot of stomach issues (very sensitive). So I have always had to eat a lot of smaller meals/snack throughout the day instead of a lot at once.

As for working out, Randolph tries to be as active as possible.

A workout is worth it even if you only have 15 minutes! My fave is hot yoga, barre, and I love long walks! she shared. I find that I always am in a better mood on the days I make time to exercise.

Between school, friends, Underwood, her family, and work obligations, Randolph strives to create a healthy balance in her life.

Has it been tough balancing school and life in general? asked another Instagram user.

Yes! I feel like this past year has thrown a bunch of things my way that Ive really had to work at learning to balance. Schoolwork definitely makes it challenging. I pretty much bring it with me everywhere I go and use most of my free time to work on it! she responded.

But Randolph has learned its all about sticking to a schedule.

Id say that the key thing in relieving my stress is making a schedule for myself and sticking to it so that I allow time for all areas of my life, she wrote.

Read more: The Bachelor: Cassie Randolph Addresses The Beef Between Her, Caelynn Miller-Keyes And Hannah Bs Crew

Originally posted here:
'The Bachelor': Cassie Randolph Reveals Her Skincare, Diet, and Workout Routine - Showbiz Cheat Sheet

Laid off? It could be the start of a better future. Here’s why – Ladders

Being laid off can be extremely stressful. In fact, on theHolmes-Rahe Life Stress Inventory/Social Readjustment Rating Scale (SRRS), losing a job ranks eighth out of 43 top life stressors. When you lose a job, particularly if youd been a long time or exceptionally loyal employee, you will likely go through a period of emotional, financial, and psychological upheaval.

Often, the shock of a layoff is compounded by job tension that may have preceded it. Difficulties maintaining a work/life balance, being overworked or underpaid, conflict with supervisors or coworkers these are all sources of stress and, according to the American Institute of Stress, job-related stress has been linked tohigh blood pressure and other health problems.

Thoughbeing laid off is not the same as being fired that is, its generally not due to poor performance or misconduct, or anything that could be construed as your fault it is a loss, and its natural to grieve a loss. Since grieving is a process, you may experience some orall of the five common stages of grief: denial, anger, bargaining, depression, and, finally, acceptance.

The good news is: There is indeed life after a layoff. Some people whove been laid off find that they emerge better, happier, and more fulfilled than before. Whether or not that happens for you depends mainly on the mindset you adopt and the actions you take. Follow these guidelines, and you may find yourself at the beginning of an exciting and fulfilling new career journey.

At this point, that layoff should be in your rear-view mirror. Its something that happened; it doesnt define you. The only way to go from here is forward.

One of the greatest mistakes people make is identifying themselves solely with the work they do. Take this opportunity to stop thinking of yourself as your job. When you are employed again, dont neglect your network, your hobbies, and your life. Maintain the healthy lifestyle youve created during this time of transition. You may find that the work you do is positively affected by the way you feel.

Kathleen Marvin is a Certified Career Coach at RiseSmart focusing on professional and personal development.

Read the rest here:
Laid off? It could be the start of a better future. Here's why - Ladders

Meet Health Coach Ellie Goldenberg – Jewish Link of Bronx, Westchester and Connecticut

Health coach Ellie Goldenberg (Credit: Ellie Goldenberg)

Ellie Goldenberg started health coaching six years ago, helping her fathers medical patients lose weight, lower blood pressure and reduce cholesterol levels. Today, Goldenberg is a certified health coach offering personalized weight-loss programs for everyone, including diabetics, seniors, teens and nursing moms; exercise programs to help maintain a healthy weight; personal training sessions; and online group exercise classes and fitness challenges. Goldenbergs motto is: Look Good, Feel Good with Coach Ellie.

Health and fitness has always been a part of my life, explained Goldenberg. I grew up in an active family of three brothers and know how to play many sports. We were always skiing, hiking or biking. Sundays were centered around some outdoor athletic adventure.

Goldenberg continued, An active lifestyle is different for everyone; sometimes it is climbing the stairs at work, sometimes parking further away at the grocery store to get more steps in, sometimes it is working out in your own home, or sometimes it is joining a gym.

I love my job as a health coach, she said. It allows me to listen to my clients, understand their health goals, find programs that best suit their needs, sensitivities, allergies, medical conditions, age, flexibility and family. I want them to not only be successful on their weight-loss journey but also feel in control of their health! When they start seeing progress, it creates positive energy. That energy leads to positive growth and a continued drive to create healthy lifelong habits.

Goldenberg realizes that challenges arise and life happens. People have busy schedules, families, events and holidays, which require added support to navigate. While consistency is optimal, she guides her clients on how to balance these events with healthy choices.

Goldenberg also believes exercise is a key for maintaining a healthy weight. Create an exercise schedule. Set time aside and do it, even if you are tired or you know it may not be your best workout, you just need to get it in. It is a habit that will lead to long-term success.

Fitness is important for the mind, too. A major part of weight loss comes from the mind. When you visualize your weight-loss goals, success is more likely in reach. Exercise clears our minds so we focus on our health through a mind-body connection, she added.

As a coach, Goldenberg guides her clients through their health programs and through their fitness journeys. I evaluate what works for their lifestyles and how they can be successful on a personalized program.

Goldenberg explained the range of her programs: I have private fitness challenge groups where I send out videos to the group, who exercise along with me on the video, on their own time, in their own home. They have the ability to interact with the group and ask questions, which creates group accountability and support.

For personal training, Goldenberg said, I work with clients one on one, and I am able to gear the session towards each persons ability. I use a combination of strength training and cardiovascular exercises. I give a fitness class through the Zoom App. I share the link with my clients and we exercise together as a group. I am in my home. You are in your home. All you do is click the link for this live class and exercise along with me.

Goldenbergs coaching empowers her clients to feel that they have healthy minds and healthy bodies. By creating a healthy lifestyle, I want to help my clients navigate dinners at home, and going out for dinner without feeling deprived, to feel included in all life activities because life happens. Goldenberg chooses programs that work with her clients goals and lifestyle, whether they work or stay at home.

Goldenberg, who is also an image consultant, defines success as when her clients are happy. When you look good and feel good, it translates into positive energy, which creates a snowball effect that encourages further success on their programs. It is also about making time for yourself and your own self-care. I have this discussion with moms all the time. We take care of our children and our homes, but often neglect ourselves. However, it is important to make time for yourself, dedicate it and block it out on your calendar. Sometimes that means waking up earlier to prepare a healthy breakfast, have a quiet cup of coffee, exercise or even a few minutes to meditate. Starting your morning off right can set the tone for the rest of the day.

To get in touch with Coach Ellie please email her at This email address is being protected from spambots. You need JavaScript enabled to view it..

By Judy Berger

See original here:
Meet Health Coach Ellie Goldenberg - Jewish Link of Bronx, Westchester and Connecticut